US20100255581A1 - Stimuli responsive nanofibers - Google Patents

Stimuli responsive nanofibers Download PDF

Info

Publication number
US20100255581A1
US20100255581A1 US12/666,168 US66616808A US2010255581A1 US 20100255581 A1 US20100255581 A1 US 20100255581A1 US 66616808 A US66616808 A US 66616808A US 2010255581 A1 US2010255581 A1 US 2010255581A1
Authority
US
United States
Prior art keywords
integer
group
aryl
alkyl
hydrogen atom
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US12/666,168
Inventor
Tahmina Naqvi
Jie Wen
Patrick Guire
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Innovative Surface Technologies LLC
Original Assignee
Innovative Surface Technologies LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Innovative Surface Technologies LLC filed Critical Innovative Surface Technologies LLC
Priority to US12/666,168 priority Critical patent/US20100255581A1/en
Publication of US20100255581A1 publication Critical patent/US20100255581A1/en
Assigned to INNOVATIVE SURFACE TECHNOLOGIES, INC. reassignment INNOVATIVE SURFACE TECHNOLOGIES, INC. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: GUIRE, PATRICK, NAQVI, TAHMINA, WEN, JIE
Abandoned legal-status Critical Current

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14Macromolecular materials
    • A61L27/16Macromolecular materials obtained by reactions only involving carbon-to-carbon unsaturated bonds
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/0068General culture methods using substrates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/28Materials for coating prostheses
    • A61L27/34Macromolecular materials
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/54Biologically active materials, e.g. therapeutic substances
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L29/00Materials for catheters, medical tubing, cannulae, or endoscopes or for coating catheters
    • A61L29/04Macromolecular materials
    • A61L29/041Macromolecular materials obtained by reactions only involving carbon-to-carbon unsaturated bonds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L29/00Materials for catheters, medical tubing, cannulae, or endoscopes or for coating catheters
    • A61L29/08Materials for coatings
    • A61L29/085Macromolecular materials
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L29/00Materials for catheters, medical tubing, cannulae, or endoscopes or for coating catheters
    • A61L29/14Materials characterised by their function or physical properties, e.g. lubricating compositions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L29/00Materials for catheters, medical tubing, cannulae, or endoscopes or for coating catheters
    • A61L29/14Materials characterised by their function or physical properties, e.g. lubricating compositions
    • A61L29/16Biologically active materials, e.g. therapeutic substances
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/04Macromolecular materials
    • A61L31/048Macromolecular materials obtained by reactions only involving carbon-to-carbon unsaturated bonds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/08Materials for coatings
    • A61L31/10Macromolecular materials
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/14Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/14Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L31/16Biologically active materials, e.g. therapeutic substances
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12MAPPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
    • C12M23/00Constructional details, e.g. recesses, hinges
    • C12M23/02Form or structure of the vessel
    • C12M23/08Flask, bottle or test tube
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12MAPPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
    • C12M23/00Constructional details, e.g. recesses, hinges
    • C12M23/20Material Coatings
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12MAPPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
    • C12M25/00Means for supporting, enclosing or fixing the microorganisms, e.g. immunocoatings
    • C12M25/14Scaffolds; Matrices
    • DTEXTILES; PAPER
    • D01NATURAL OR MAN-MADE THREADS OR FIBRES; SPINNING
    • D01DMECHANICAL METHODS OR APPARATUS IN THE MANUFACTURE OF ARTIFICIAL FILAMENTS, THREADS, FIBRES, BRISTLES OR RIBBONS
    • D01D5/00Formation of filaments, threads, or the like
    • D01D5/0007Electro-spinning
    • DTEXTILES; PAPER
    • D01NATURAL OR MAN-MADE THREADS OR FIBRES; SPINNING
    • D01FCHEMICAL FEATURES IN THE MANUFACTURE OF ARTIFICIAL FILAMENTS, THREADS, FIBRES, BRISTLES OR RIBBONS; APPARATUS SPECIALLY ADAPTED FOR THE MANUFACTURE OF CARBON FILAMENTS
    • D01F1/00General methods for the manufacture of artificial filaments or the like
    • D01F1/02Addition of substances to the spinning solution or to the melt
    • D01F1/10Other agents for modifying properties
    • DTEXTILES; PAPER
    • D01NATURAL OR MAN-MADE THREADS OR FIBRES; SPINNING
    • D01FCHEMICAL FEATURES IN THE MANUFACTURE OF ARTIFICIAL FILAMENTS, THREADS, FIBRES, BRISTLES OR RIBBONS; APPARATUS SPECIALLY ADAPTED FOR THE MANUFACTURE OF CARBON FILAMENTS
    • D01F6/00Monocomponent artificial filaments or the like of synthetic polymers; Manufacture thereof
    • D01F6/02Monocomponent artificial filaments or the like of synthetic polymers; Manufacture thereof from homopolymers obtained by reactions only involving carbon-to-carbon unsaturated bonds
    • D01F6/20Monocomponent artificial filaments or the like of synthetic polymers; Manufacture thereof from homopolymers obtained by reactions only involving carbon-to-carbon unsaturated bonds from polymers of cyclic compounds with one carbon-to-carbon double bond in the side chain
    • D01F6/22Monocomponent artificial filaments or the like of synthetic polymers; Manufacture thereof from homopolymers obtained by reactions only involving carbon-to-carbon unsaturated bonds from polymers of cyclic compounds with one carbon-to-carbon double bond in the side chain from polystyrene
    • DTEXTILES; PAPER
    • D01NATURAL OR MAN-MADE THREADS OR FIBRES; SPINNING
    • D01FCHEMICAL FEATURES IN THE MANUFACTURE OF ARTIFICIAL FILAMENTS, THREADS, FIBRES, BRISTLES OR RIBBONS; APPARATUS SPECIALLY ADAPTED FOR THE MANUFACTURE OF CARBON FILAMENTS
    • D01F6/00Monocomponent artificial filaments or the like of synthetic polymers; Manufacture thereof
    • D01F6/02Monocomponent artificial filaments or the like of synthetic polymers; Manufacture thereof from homopolymers obtained by reactions only involving carbon-to-carbon unsaturated bonds
    • D01F6/26Monocomponent artificial filaments or the like of synthetic polymers; Manufacture thereof from homopolymers obtained by reactions only involving carbon-to-carbon unsaturated bonds from other polymers
    • DTEXTILES; PAPER
    • D01NATURAL OR MAN-MADE THREADS OR FIBRES; SPINNING
    • D01FCHEMICAL FEATURES IN THE MANUFACTURE OF ARTIFICIAL FILAMENTS, THREADS, FIBRES, BRISTLES OR RIBBONS; APPARATUS SPECIALLY ADAPTED FOR THE MANUFACTURE OF CARBON FILAMENTS
    • D01F6/00Monocomponent artificial filaments or the like of synthetic polymers; Manufacture thereof
    • D01F6/58Monocomponent artificial filaments or the like of synthetic polymers; Manufacture thereof from homopolycondensation products
    • D01F6/62Monocomponent artificial filaments or the like of synthetic polymers; Manufacture thereof from homopolycondensation products from polyesters
    • D01F6/625Monocomponent artificial filaments or the like of synthetic polymers; Manufacture thereof from homopolycondensation products from polyesters derived from hydroxy-carboxylic acids, e.g. lactones
    • DTEXTILES; PAPER
    • D06TREATMENT OF TEXTILES OR THE LIKE; LAUNDERING; FLEXIBLE MATERIALS NOT OTHERWISE PROVIDED FOR
    • D06MTREATMENT, NOT PROVIDED FOR ELSEWHERE IN CLASS D06, OF FIBRES, THREADS, YARNS, FABRICS, FEATHERS OR FIBROUS GOODS MADE FROM SUCH MATERIALS
    • D06M15/00Treating fibres, threads, yarns, fabrics, or fibrous goods made from such materials, with macromolecular compounds; Such treatment combined with mechanical treatment
    • D06M15/19Treating fibres, threads, yarns, fabrics, or fibrous goods made from such materials, with macromolecular compounds; Such treatment combined with mechanical treatment with synthetic macromolecular compounds
    • D06M15/21Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds
    • D06M15/285Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds of unsaturated carboxylic acid amides or imides
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2400/00Materials characterised by their function or physical properties
    • A61L2400/12Nanosized materials, e.g. nanofibres, nanoparticles, nanowires, nanotubes; Nanostructured surfaces
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2533/00Supports or coatings for cell culture, characterised by material
    • C12N2533/30Synthetic polymers
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2537/00Supports and/or coatings for cell culture characterised by physical or chemical treatment
    • C12N2537/10Cross-linking
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2539/00Supports and/or coatings for cell culture characterised by properties
    • DTEXTILES; PAPER
    • D06TREATMENT OF TEXTILES OR THE LIKE; LAUNDERING; FLEXIBLE MATERIALS NOT OTHERWISE PROVIDED FOR
    • D06MTREATMENT, NOT PROVIDED FOR ELSEWHERE IN CLASS D06, OF FIBRES, THREADS, YARNS, FABRICS, FEATHERS OR FIBROUS GOODS MADE FROM SUCH MATERIALS
    • D06M2400/00Specific information on the treatment or the process itself not provided in D06M23/00-D06M23/18
    • D06M2400/01Creating covalent bondings between the treating agent and the fibre

Definitions

  • the present invention generally relates to stimuli responsive nanofibers and stimuli responsive nanofiber modified surfaces. More particularly, the present invention is directed to nanofibers including a thermally responsive polymer, a multi-functional cross-linking agent, and optionally a biologically active material or a functional polymer that is reactive with a biologically active material.
  • the stimuli responsive nanofibers can be used to modify a surface of a substrate, such as a cell culture device.
  • Nanofibers are being considered for a variety of applications because of their unique properties including high surface area, small fiber diameter, layer thinness, high permeability, and low basis weight. More attention has been focused on functionalized nanofibers having the capability of incorporating active chemistry, especially in biomedical applications such as wound dressing, biosensors and scaffolds for tissue engineering.
  • Nanofibers may be fabricated by electrostatic spinning (also referred to as electrospinning).
  • electrospinning also referred to as electrospinning.
  • the technique of electrospinning of liquids and/or solutions capable of forming fibers is well known and has been described in a number of patents, such as, for example, U.S. Pat. Nos. 4,043,331 and 5,522,879.
  • the process of electrospinning generally involves the introduction of a solution or liquid into an electric field, so that the solution or liquid is caused to produce fibers. These fibers are generally drawn to a conductor at an attractive electrical potential for collection. During the conversion of the solution or liquid into fibers, the fibers harden and/or dry.
  • This hardening and/or drying may be caused by cooling of the liquid, i.e., where the liquid is normally a solid at room temperature; by evaporation of a solvent, e.g., by dehydration (physically induced hardening); or by a curing mechanism (chemically induced hardening).
  • Nanofibers ranging from 50 nm to 5 ⁇ m in diameter can be electrospun into a nonwoven or an aligned nanofiber mesh. Due to the small fiber diameters, electrospun textiles inherently possess a very high surface area and a small pore size. These properties make electrospun fabrics potential candidates for a number of applications including: membranes, tissue scaffolding, and other biomedical applications.
  • Nanofibers can be used to modify the surface of a substrate to achieve a desired surface characteristic. Most nanofiber surfaces have to be engineered to obtain the ability to immobilize biomolecules. Surface modification of synthetic biomaterials, with the intent to improve biocompatibility, has been extensively studied, and many common techniques have been considered for polymer nanofiber modification. For example, Sanders et al in “Fibro-Porous Meshes Made from Polyurethane Micro-Fibers: Effects of Surface Charge on Tissue Response” Biomaterials 26, 813-818 (2005) introduced different surface charges on electrospun polyurethane (PU) fiber surfaces through plasma-induced surface polymerization of negatively or positively charged monomers.
  • PU electrospun polyurethane
  • the surface charged PU fiber mesh was implanted in rat subcutaneous dorsum for 5 weeks to evaluate tissue compatibility, and it was found that negatively charged surfaces may facilitate vessel ingrowth into the fibroporous mesh biomaterials.
  • PET Electrospun Polyethylene Terephthalate
  • PET polyethylene terephthalate
  • the present invention is a stimuli responsive nanofiber including a stimuli responsive polymer.
  • a stimuli responsive nanofiber is a thermally responsive nanofiber including a thermally responsive polymer.
  • the stimuli responsive nanofiber may include a cross-linking agent having at least two latent reactive activatable groups.
  • photochemically, electrochemically or thermally latent reactive groups will form covalent bonds when subjected to a source of energy.
  • Suitable energy sources include radiation, electrical and thermal energy.
  • the radiation energy is visible, ultraviolet, infrared, x-ray or microwave electromagnetic radiation.
  • the cross-linking agent may have at least two latent reactive activatable groups. These latent reactive groups may be the same or may be different. For example, all of the latent reactive groups may be photochemically reactive groups. Alternatively, in other embodiments of the invention the cross-linking agent may include both photochemically and thermally reactive groups. Further, the cross-linking agent may be monomeric or polymeric materials or may be a mixture of both monomeric and polymeric materials.
  • the thermally responsive polymer is poly(isopropylacrylamide) as well as derivatives of poly(isopropylacrylamide) such as graft copolymer derivatives with polyethylene glycol derivatives.
  • the present invention is a method of treating a surface of a substrate including the steps of combining a stimuli responsive polymer, such as a thermally responsive polymer, and a cross-linking agent having at least two latent reactive activatable groups; forming at least one nanofiber from the combined mixture; contacting the surface with the nanofiber; and forming a bond between the nanofiber and the surface.
  • a stimuli responsive polymer such as a thermally responsive polymer
  • a cross-linking agent having at least two latent reactive activatable groups
  • the present invention is a surface coating for a surface of an article.
  • the surface coating includes a stimuli responsive nanofiber including a nanofiber coated with a stimuli responsive polymer, such as a thermally responsive polymer, and a cross-linking agent having at least two latent reactive activatable groups.
  • the coated nanofiber or the coated surface may include a biologically active material or, alternatively, a functional polymer.
  • the present invention is an article including a surface coating having a thermally responsive nanofiber.
  • the thermally responsive nanofiber includes a thermally responsive polymer and a cross-linking agent having at least two latent reactive activatable groups.
  • the present invention is a cell culture device including a surface coating having a thermally responsive nanofiber.
  • the thermally responsive nanofiber includes a thermally responsive polymer, a cross-linking agent having at least two latent reactive activatable groups, and a biologically active material.
  • the stimuli responsive nanofiber may have a diameter ranging from 1 to 100 microns and still other embodiments may have a diameter ranging from 1 nm to 1000 nm.
  • the stimuli responsive nanofiber may have an aspect ratio in a range of about at least 10 to at least 100.
  • the thermally responsive nanofiber has first physical property at a first predetermined temperature range and a second physical property at a second predetermined temperature range.
  • the thermally responsive nanofiber is capable of transitioning from a first physical property to a second physical property upon the application or removal of heat to or from the system
  • FIG. 1 is an electronic image of a polycaprolactone nanofiber described in Example 1.
  • FIG. 2 is an electronic image of a polyisopropylacrylamide nanofiber described in Example 3.
  • FIGS. 3 and 4 illustrate protein absorption profiles of polyisopropylacrylamide coated polystyrene and polyisopropylacrylamide nanofibers described in Example 4.
  • FIGS. 5 and 6 are electronic images of cell lift up times from various surfaces described in Example 5.
  • FIG. 7 is an electronic image of T47-D cells cultured on nanofiber and flat surfaces.
  • FIG. 8 is an electronic image of replated BAEC cells.
  • Stimuli responsive or “smart” materials are materials that have one or more properties that can be altered in a controlled fashion by the application of external stimuli, such as stress, temperature, moisture, pH, applied electric or magnetic fields, ionic strength, or biomolecules such as glucose or antigens.
  • external stimuli such as stress, temperature, moisture, pH, applied electric or magnetic fields, ionic strength, or biomolecules such as glucose or antigens.
  • Representative stimuli responsive materials and polymers as well as their physical characteristic are reported by Gil et al., “Stimuli-responsive polymers and their bioconjugates,” Prog. Polym. Sci., 29, 1173-1222 (2004) which is incorporated by reference herein.
  • a thermally responsive polymer is one example of these materials.
  • a thermally responsive material is a material in which a physical property is altered in response to a change in temperature in the surrounding environment or system.
  • a thermally responsive polymer may change from a hydrophilic state to hydrophobic state when the temperature of the system or its surroundings rises above a lower critical solution temperature (LCST).
  • LCST critical solution temperature
  • the thermally responsive nanofiber can be used to modify a surface of a substrate to provide a functionalized surface. More particularly, the thermally responsive nanofiber can be used to provide a thermally responsive surface on a substrate.
  • the physical property of the thermally responsive nanofiber modified surface of the substrate changes in response to a change in temperature in the system.
  • Biologically active materials can be immobilized on the nanofiber modified surface by reacting with the functional groups accessible or exposed on the surface of the substrate. Typically, the biologically active materials retain all or a portion of their bioactivity after having been immobilized on the thermally responsive nanofiber modified surface.
  • the ability of biologically active materials to bond with the surface of the substrate can be affected depending on the physical state of the modified surface. Thus, by controlling the temperature of the modified surface, the ability to bind to a biological material can be controlled.
  • the thermally responsive nanofiber includes a thermally responsive polymer, a biologically active material, and a cross-linking agent having at least two latent reactive activatable groups.
  • the thermally responsive nanofiber can be used to modify the surface of a substrate by bonding the nanofiber to the surface by the formation of a covalent bond between the surface of the substrate and the nanofiber.
  • At least one of the latent reactive activatable groups undergoes activation when subjected to a suitable energy source to form a covalent bond between the surface of the substrate and the thermally responsive nanofiber.
  • the remaining latent reactive group(s) are left accessible or exposed on the surface of the substrate.
  • the biologically active material included in the nanofiber or the accessible or exposed latent reactive groups on the surface may be used for further surface modification of the substrate.
  • a number of processing techniques such as drawing, template synthesis, phase separation, self-assembly or electrospinning have been used to prepare nanofibers.
  • a thermally responsive nanofiber can be formed by electrospinning a fiber-forming combination that includes a thermally responsive polymer, a biologically active material, and a cross-linking agent having at least two latent reactive activatable groups.
  • Electrospinning generally involves the introduction of a polymer or other fiber-forming solution or liquid into an electric field, so that the solution or liquid is caused to produce fibers.
  • a strong electrostatic field is applied to a fiber-forming combination held in a syringe with a capillary outlet, a pendant droplet of the fiber-forming mixture from the capillary outlet is deformed into a Taylor cone.
  • the electric forces overcome the surface tension on the droplet, and a charged jet of the solution or liquid is ejected from the tip of the Taylor cone.
  • the ejected jet then moves toward a collecting metal screen that acts as a counterelectrode having a lower electrical potential.
  • the jet is split into small charged fibers or fibrils and any solvent present evaporates leaving behind a nonwoven fabric mat formed on the screen.
  • electrostatically spun fibers can be produced having very thin diameters. Parameters that influence the diameter, consistency, and uniformity of the electrospun fibers include the thermally responsive polymer, the molecular weight of the polymer; the cross-linker concentration (loading) in the fiber-forming mixture, the flow rate of the polymer solution, the applied voltage, and the needle collector distance.
  • a stimuli responsive nanofiber has a diameter ranging from about 1 nm to about 100 ⁇ m. In other embodiments, the stimuli responsive nanofiber has a diameter in a range of about 1 nm to about 1000 nm. Further, the nanofiber may have an aspect ratio in a range of about at least 10 to about at least 100.
  • the fibers have a high surface area per unit of mass. This high surface area to mass ratio permits fiber-forming material solutions to be transformed from solvated fiber-forming materials to solid nanofibers in fractions of a second.
  • the stimuli responsive polymer used to form the nanofiber may be selected from any stimuli responsive, fiber-forming material that is compatible with the cross-linking agent.
  • a selected thermally responsive polymer should be capable of undergoing a rapid change from a first physical property to a second physical property when the temperature of the system has risen above a lower critical solution temperature.
  • Exemplary thermally responsive, fiber forming polymers include, but are not limited to, poly(isopropylacrylamide) and mixtures and copolymers thereof.
  • Other thermally responsive polymers include random copolymers of 2-(2-methoxyethoxy)ethyl methacrylate and oligo(ethylene glycol) methacrylate.
  • the thermally responsive polymer is poly(isopropylacrylamide).
  • Poly(isopropylacrylamide) changes from a primarily hydrophobic state to a primarily hydrophilic state upon reaching a lower critical solution temperature of approximately 20 to 32° C.
  • Poly-N-isopropylacrylamide (PIPAAm) has been one of the most studied thermo-responsive polymer not only because it displays a low critical solution temperature (LCST) of around 32° C., close to body temperature, but also because its LCST is relatively insensitive to environmental conditions. Slight variations of pH, concentration or chemical environment affect the LCST by only a few degrees.
  • the main mechanism of PIPAAm's aqueous phase separation is the thermally induced release of water molecules bound to polymer isopropyl side groups, resulting in intra- and intermolecular hydrophobic interactions between isopropyl groups above the LCST.
  • cross-linking agents within the composition forming the thermally responsive nanofiber, allows the thermally responsive nanofiber to be compatible with a wide range of support surfaces.
  • the latent reactive cross-linking agents can be used alone or in combination with other materials to provide a desired surface characteristic.
  • Suitable cross-linking agents include either monomeric (small molecule materials) or polymeric materials having at least two latent reactive activatable groups that are capable of forming covalent bonds with other materials when subjected to a source of energy such as radiation, electrical or thermal energy.
  • latent reactive activatable groups are chemical entities that respond to specific applied external energy or stimuli to generate active species with resultant covalent bonding to an adjacent chemical structure.
  • Latent reactive groups are those groups that retain their covalent bonds under storage conditions but that form covalent bonds with other molecules upon activation by an external energy source.
  • latent reactive groups form active species such as free radicals. These free radicals may include nitrenes, carbine or excited states of ketones upon absorption of externally applied electric, electromagnetic or thermal energy.
  • Various examples of known latent reactive groups are reported in U.S. Pat. Nos. 4,973,493; 5,258,041; 5,563,056; 5,637,460; or 6,278,018.
  • the eight compounds include 2,4,6-tris(trichloromethyl)-1,3,5 triazine, 2-(methyl)-4,6-bis(trichloromethyl)-1,3,5-triazine, 2-(4-methoxynaphthyl)-4,6-bis(trichloromethyl)-1,3,5-triazine, 2-(4-ethoxynaphthyl)-4,6-bis(trichloromethyl)-1,3,5-triazine, 4-(4-carboxylphenyl)-2,6-bis(trichloromethyl)-1,3,5-triazine, 2-(4-methoxyphenyl)-4,6-bis(trichloromethyl)-1,3,5-triazine, 2-(1-ethen-2-2′-furyl)-4,6-bis(trichloromethyl)-1,3,5-triazine and 2-(4-methoxystyryl)-4,6-bis(trichloromethyl)
  • the latent reactive groups are the same, while in other embodiments the latent reactive groups may be different.
  • the latent reactive groups may be two different groups that are both activated by radiation.
  • one latent reactive group may by activated by radiation while another latent reactive group may be activated by heat.
  • Suitable cross-linking agents include bi-, tri- and multi-functional monomeric and polymeric materials.
  • Latent reactive groups that are reactive to thermal or heat energy include a variety of reactive moieties and may include known compounds that decompose thermally to form reactive species that will then form covalent bonds.
  • the covalent bonds allow the cross-linking to bind to adjacent materials.
  • Suitable thermally-reactive groups typically have a pair of atoms having a heat sensitive or labile bond.
  • Heat labile bonds include oxygen-oxygen bonds such as peroxide bonds, nitrogen-oxygen bonds, and nitrogen-nitrogen bonds. Such bonds will react or decompose at temperatures in a range of not more than 80-200° C.
  • thermally generated carbenes and nitrenes undergo a variety of chemical reactions, including carbon bond insertion, migration, hydrogen abstraction, and dimerization.
  • carbene generators include diazirines and diazo-compounds.
  • nitrene generators include aryl azides, particularly perfluorinated aryl azides, acyl azides, and triazolium ylides.
  • groups that upon heating form reactive triplet states such as dioxetanes, or radical anions and radical cations may also be used to form the thermally-reactive group.
  • the thermally-reactive group of the cross-linking agent includes a peroxide —(O—O)— group.
  • Thermally-reactive peroxide-containing groups include, for example, thermally-reactive diacyl peroxide groups, thermally-reactive peroxydicarbonate groups, thermally-reactive dialkylperoxide groups, thermally-reactive peroxyester groups, thermally-reactive peroxyketal groups, and thermally-reactive dioxetane groups.
  • Dioxetanes are four-membered cyclic peroxides that react or decompose at lower temperatures compared to standard peroxides due to the ring strain of the molecules.
  • the initial step in the decomposition of dioxetanes is cleavage of the O—O bond
  • the second step breaks the C—C bond creating one carbonyl in the excited triplet state, and one in an excited singlet state.
  • the excited triplet state carbonyl can extract a hydrogen from an adjacent material, forming two radical species, one on the adjacent material and one on the carbon of the carbonyl with the oxygen and will form a new covalent bond between the thermally reactive dioxetane and the adjacent material.
  • thermally reactive moieties are reported in US 20060030669 and other representative thermal latent reactive groups are reported in U.S. Pat. No. 5,258,041. Both of these documents are hereby incorporated by reference.
  • Latent reactive groups that are reactive to electromagnetic radiation, such as ultraviolet or visible radiation, are typically referred to as photochemical reactive groups.
  • latent reactive activatable species in the form of latent reactive activatable aryl ketones is useful.
  • exemplary latent reactive activatable aryl ketones include acetophenone, benzophenone, anthraquinone, anthrone, anthrone-like heterocycles (i.e., heterocyclic analogs of anthrone such as those having N, O, or S in the 10-position), and their substituted (e.g., ring substituted) derivatives.
  • aryl ketones include heterocyclic derivatives of anthrone, including acridone, xanthone, and thioxanthone, and their ring substituted derivatives. In particular, thioxanthone, and its derivatives, having excitation energies greater than about 360 nm are useful.
  • ketones are suitable since they are readily capable of undergoing an activation/inactivation/reactivation cycle.
  • Benzophenone is an exemplary photochemically reactive activatable group, since it is capable of photochemical excitation with the initial formation of an excited singlet state that undergoes intersystem crossing to the triplet state.
  • the excited triplet state can insert into carbon-hydrogen bonds by abstraction of a hydrogen atom (from a support surface, for example), thus creating a radical pair. Subsequent collapse of the radical pair leads to formation of a new carbon-carbon bond.
  • a reactive bond e.g., carbon-hydrogen
  • the ultraviolet light-induced excitation of the benzophenone group is reversible and the molecule returns to ground state energy level upon removal of the energy source.
  • Photochemically reactive activatable aryl ketones such as benzophenone and acetophenone are of particular importance inasmuch as these groups are subject to multiple reactivation in water and hence provide increased coating efficiency.
  • photochemically reactive cross-linking agents may be derived from three different types of molecular families. Some families include one or more hydrophilic portions, i.e., a hydroxyl group (that may be protected), amines, alkoxy groups, etc. Other families may include hydrophobic and amphiphilic portions. In one embodiment, the family has the formula:
  • L is a linking group.
  • D is O, S, SO, SO 2 , NR 5 or CR 6 R 7 .
  • T is (—CH 2 —) x , (—CH 2 CH 2 —O—) x , (—CH 2 CH 2 CH 2 —O—) x or (—CH 2 CH 2 CH 2 CH 2 —O—) x .
  • R 1 is a hydrogen atom, an alkyl, alkyloxyalkyl, aryl, aryloxyalkyl or aryloxyaryl group.
  • X is O, S, or NR 8 R 9 .
  • P is a hydrogen atom or a protecting group, with the proviso that P is absent when X is NR 8 R 9 .
  • R 2 is a hydrogen atom, an alkyl, alkyloxyalkyl, aryl, aryloxylalkyl or aryloxyaryl group.
  • G is O, S, SO, SO 2 , NR 10 , (CH 2 ) t —O— or C ⁇ O.
  • R 3 and R 4 are each independently an alkyl, aryl, arylalkyl, heteroaryl, or a heteroarylalkyl group or when R 3 and R 4 are tethered together via (—CH 2 —) q , (—CH 2 —) r C ⁇ O(—CH 2 —) s , (—CH 2 —) r S(—CH 2 —) s , (—CH 2 —) r S ⁇ O(—CH 2 —) s , (—CH 2 —) r S(O) 2 (—CH 2 —) s , or (—CH 2 —) r NR(—CH 2 —) s .
  • R 5 and R 10 are each independently a hydrogen atom or an alkyl, aryl, or arylalkyl group.
  • R 6 and R 7 are each independently a hydrogen atom, an alkyl, aryl, arylalkyl, heteroaryl or heteroarylalkyl group.
  • R 8 and R 9 are each independently a hydrogen atom, an alkyl, aryl, or arylalkyl group, R is a hydrogen atom, an alkyl group or an aryl group, q is an integer from 1 to about 7, r is an integer from 0 to about 3, s is an integer from 0 to about 3, m is an integer from 2 to about 10, t is an integer from 1 to about 10 and x is an integer from 1 to about 500.
  • L is a branched or unbranched alkyl chain having between about 2 and about 10 carbon atoms.
  • D is an oxygen atom (O).
  • T is (—CH 2 —) x or (—CH 2 CH 2 —O—) x and x is 1 or 2.
  • R 1 is a hydrogen atom.
  • X is an oxygen atom
  • O is an oxygen atom
  • P is a hydrogen atom
  • R 2 is a hydrogen atom.
  • G is an oxygen atom, O.
  • R 3 and R 4 are each individually aryl groups, which can be further substituted, and m is 3.
  • L is N
  • D is O
  • T is (—CH 2 —) x
  • R 1 is a hydrogen atom
  • X is O
  • P is a hydrogen atom
  • R 2 is a hydrogen atom
  • G is O
  • R 3 and R 4 are phenyl groups
  • m is 3 and x is 1.
  • L is (—CH 2 —) y
  • D is O
  • T is (—CH 2 —) z
  • R 1 is a hydrogen atom
  • X is O
  • P is a hydrogen atom
  • R 2 is a hydrogen atom
  • G is O
  • R 3 and R 4 are phenyl groups
  • m is 2
  • x is 1 and y is an integer from 2 to about 6, and in particular, y is 2, 4 or 6.
  • x is an integer from about 1 to about 500, more particularly from about 1 to about 400, from about 1 to about 250, from about 1 to about 200, from about 1 to about 150, from about 1 to about 100, from about 1 to about 50, from about 1 to about 25 or from about 1 to about 10.
  • the family has the formula:
  • T, R 1 , X, P, R 2 , G, R 3 , R 4 , R 8 , R 9 , R 10 , R, q, r, s, m, t and x are as defined above.
  • L has a formula according to structure (I):
  • a and J are each independently a hydrogen atom, an alkyl group, an aryl group, or together with B form a cyclic ring, provided when A and J are each independently a hydrogen atom, an alkyl group, or an aryl group then B is not present, B is NR 11 , O, or (—CH 2 —) z , provided when A, B and J form a ring, then A and J are (—CH 2 —) z or C ⁇ O, R 11 is a hydrogen atom, an alkyl group, an aryl group or denotes a bond with T, each z independently is an integer from 0 to 3 and provided when either A or J is C ⁇ O, then B is NR 11 , O, or (—CH 2 —) z and z must be at least 1.
  • T is —CH 2 —.
  • the family has the formula: L-((GTZR 3 C( ⁇ O)R 4 )) m , and L, T, G, R 3 , R 4 , R 10 , R, q, r, s, m, t and x are as defined above.
  • Z can be a C ⁇ O, COO or CONH when T is (—CH 2 —) x .
  • L has a formula according to structure (I):
  • A, B, J, R 11 , and z are as defined above.
  • L has a formula according to structure (II):
  • R 12 , R 13 , R 14 , R 15 , R 16 , R 17 are each independently a hydrogen atom, an alkyl or aryl group or denotes a bond with T, provided at least two of R 12 , R 13 , R 14 , R 15 , R 16 , R 17 are bonded with T and each K, independently is CH or N.
  • the family has the formula:
  • T is (—CH 2 —) x , (—CH 2 CH 2 —O—) x , (—CH 2 CH 2 CH 2 —O—) x , (—CH 2 CH 2 CH 2 CH 2 —O—) x or forms a bond.
  • Q is (—CH 2 —) p , (—CH 2 CH 2 —O—) p , (—CH 2 CH 2 CH 2 —O—) p or (—CH 2 CH 2 CH 2 CH 2 —O—) p and p is an integer from 1 to about 10.
  • L has a formula according to structure (I):
  • A, B, J, R 11 , and z are as defined above.
  • L has a formula according to structure (II):
  • R 12 , R 13 , R 14 , R 15 , R 16 , R 17 are each independently a hydrogen atom, an alkyl or aryl group or denotes a bond with T, provided at least two of R 12 , R 13 , R 14 , R 15 , R 16 , R 17 are bonded with T and each K, independently is CH or N.
  • compounds of the present invention provide that R 3 and R 4 are both phenyl groups and are tethered together via a CO, a S or a CH 2 .
  • compounds of the present invention provide when R 3 and R 4 are phenyl groups, the phenyl groups can each independently be substituted with at least one alkyloxyalkyl group, such as CH 3 O—(CH 2 CH 2 O—) n —, or CH 3 O(—CH 2 CH 2 CH 2 O—) n — a hydroxylated alkoxy group, such as HO—CH 2 CH 2 O—, HO(—CH 2 CH 2 O—) n — or HO(—CH 2 CH 2 CH 2 O—) n —, etc. wherein n is an integer from 1 to about 10.
  • each R, R 1 , each G, each R 3 , each R 4 , each R 10 , each q, each r, each s, each t and m are as defined above and xx is an integer from 1 to about 10.
  • L has a formula according to structure (I):
  • A, B, J, R 11 , and z are as defined above.
  • a and B are both hydrogen atoms.
  • xx is 1.
  • R 1 is H.
  • G is (—CH 2 —) t O— and t is 1.
  • R 3 and R 4 are each individually aryl groups.
  • xx is 1, R 1 is H, each G is (—CH 2 —) t O—, t is 1 and each of R 3 and R 4 are each individually aryl groups.
  • the family has the formula:
  • L, R, R 1 , R 2 , R 3 , R 4 , R 8 , R 9 , R 10 , X, P, G, q, r, s, t, and m are as defined above.
  • L is N
  • R 20 and R 21 are each individually a hydrogen atom, an alkyl group or an aryl group.
  • R 1 is H.
  • P is H.
  • R 2 is H.
  • G is (—CH 2 —) t O— and t is 1.
  • R 3 and R 4 are each individually aryl groups.
  • R 1 is H
  • X is O
  • P is H
  • R 2 is H
  • G is (—CH 2 —) t O—
  • t is 1
  • R 3 and R 4 are each individually aryl groups and R 20 and R 21 are both methyl groups.
  • the present invention provides a family of compounds having the formula:
  • L is a linking group
  • G is O, S, SO, SO 2 , NR 10 , (CH 2 ) t —O— or C ⁇ O
  • R 3 and R 4 are each independently an alkyl, aryl, arylalkyl, heteroaryl, or an heteroarylalkyl group or when R 3 and R 4 are tethered together via (—CH 2 —) q , (—CH 2 —) r C ⁇ O(—CH 2 —) s , (—CH 2 —) r S(—CH 2 —) s , (—CH 2 —) r S ⁇ O(—CH 2 —) s or (—CH 2 —) r S(O) 2 (—CH 2 —) s , (—CH 2 —) r NR(—CH 2 —) s ;
  • R 10 is a hydrogen atom or an alkyl, aryl, or an arylalkyl group;
  • R is a
  • L is N
  • G is C ⁇ O.
  • R 3 and R 4 are each individually aryl groups.
  • G is C ⁇ O and R 3 and R 4 are each individually aryl groups.
  • Alkyl by itself or as part of another substituent refers to a saturated or unsaturated branched, straight-chain or cyclic monovalent hydrocarbon radical having the stated number of carbon atoms (i.e., C 1 -C 6 means one to six carbon atoms) that is derived by the removal of one hydrogen atom from a single carbon atom of a parent alkane, alkene or alkyne.
  • Typical alkyl groups include, but are not limited to, methyl; ethyls such as ethanyl, ethenyl, ethynyl; propyls such as propan-1-yl, propan-2-yl, cyclopropan-1-yl, prop-1-en-1-yl, prop-1-en-2-yl, prop-2-en-1-yl, cycloprop-1-en-1-yl; cycloprop-2-en-1-yl, prop-1-yn-1-yl, prop-2-yn-1-yl, etc.; butyls such as butan-1-yl, butan-2-yl, 2-methyl-propan-1-yl, 2-methyl-propan-2-yl, cyclobutan-1-yl, but-1-en-1-yl, but-1-en-2-yl, 2-methyl-prop-1-en-1-yl, but-2-en-2-yl, buta-1,3-die
  • alkanyl alkenyl
  • alkynyl alkynyl
  • Alkanyl by itself or as part of another substituent refers to a saturated branched, straight-chain or cyclic alkyl derived by the removal of one hydrogen atom from a single carbon atom of a parent alkane.
  • Typical alkanyl groups include, but are not limited to, methanyl; ethanyl; propanyls such as propan-1-yl, propan-2-yl(isopropyl), cyclopropan-1-yl, etc.; butanyls such as butan-1-yl, butan-2-yl(sec-butyl), 2-methyl-propan-1-yl(isobutyl), 2-methyl-propan-2-yl(t-butyl), cyclobutan-1-yl, etc.; and the like.
  • Alkenyl by itself or as part of another substituent refers to an unsaturated branched, straight-chain or cyclic alkyl having at least one carbon-carbon double bond derived by the removal of one hydrogen atom from a single carbon atom of a parent alkene.
  • the group may be in either the cis or trans conformation about the double bond(s).
  • Typical alkenyl groups include, but are not limited to, ethenyl; propenyls such as prop-1-en-1-yl, prop-1-en-2-yl, prop-2-en-1-yl, prop-2-en-2-yl, cycloprop-1-en-1-yl; cycloprop-2-en-1-yl; butenyls such as but-1-en-1-yl, but-1-en-2-yl, 2-methyl-prop-1-en-1-yl, but-2-en-1-yl, but-2-en-2-yl, buta-1,3-dien-1-yl, buta-1,3-dien-2-yl, cyclobut-1-en-1-yl, cyclobut-1-en-3-yl, cyclobuta-1,3-dien-1-yl, etc.; and the like.
  • Alkyloxyalkyl refers to a moiety having two alkyl groups tethered together via an oxygen bond. Suitable alkyloxyalkyl groups include polyoxyalkylenes, such as polyethyleneoxides, polypropyleneoxides, etc. that are terminated with an alkyl group, such as a methyl group. A general formula for such compounds can be depicted as R′—(OR′′) n or (R′O) n R′′ wherein n is an integer from 1 to about 10, and R′ and R′′ are alkyl or alkylene groups.
  • Alkynyl by itself or as part of another substituent refers to an unsaturated branched, straight-chain or cyclic alkyl having at least one carbon-carbon triple bond derived by the removal of one hydrogen atom from a single carbon atom of a parent alkyne.
  • Typical alkynyl groups include, but are not limited to, ethynyl; propynyls such as prop-1-yn-1-yl, prop-2-yn-1-yl, etc.; butynyls such as but-1-yn-1-yl, but-1-yn-3-yl, but-3-yn-1-yl, etc.; and the like.
  • Alkyldiyl by itself or as part of another substituent refers to a saturated or unsaturated, branched, straight-chain or cyclic divalent hydrocarbon group having the stated number of carbon atoms (i.e., C 1 -C 6 means from one to six carbon atoms) derived by the removal of one hydrogen atom from each of two different carbon atoms of a parent alkane, alkene or alkyne, or by the removal of two hydrogen atoms from a single carbon atom of a parent alkane, alkene or alkyne.
  • the two monovalent radical centers or each valency of the divalent radical center can form bonds with the same or different atoms.
  • Typical alkyldiyl groups include, but are not limited to, methandiyl; ethyldiyls such as ethan-1,1-diyl, ethan-1,2-diyl, ethen-1,1-diyl, ethen-1,2-diyl; propyldiyls such as propan-1,1-diyl, propan-1,2-diyl, propan-2,2-diyl, propan-1,3-diyl, cyclopropan-1,1-diyl, cyclopropan-1,2-diyl, prop-1-en-1,1-diyl, prop-1-en-1,2-diyl, prop-2-en-1,2-diyl, prop-1-en-1,3-diyl, cycloprop-1-en-1,2-diyl, cycloprop-2-en-1,2-diyl, cycloprop-2-en-1,2-d
  • alkanyldiyl alkenyldiyl and/or alkynyldiyl
  • alkylidene alkylidene
  • the alkyldiyl groups are saturated acyclic alkanyldiyl groups in which the radical centers are at the terminal carbons, e.g., methandiyl(methano); ethan-1,2-diyl(ethano); propan-1,3-diyl(propano); butan-1,4-diyl(butano); and the like (also referred to as alkylenes, defined infra).
  • Alkylene by itself or as part of another substituent refers to a straight-chain saturated or unsaturated alkyldiyl group having two terminal monovalent radical centers derived by the removal of one hydrogen atom from each of the two terminal carbon atoms of straight-chain parent alkane, alkene or alkyne. The location of a double bond or triple bond, if present, in a particular alkylene is indicated in square brackets.
  • Typical alkylene groups include, but are not limited to, methylene (methano); ethylenes such as ethano, etheno, ethyno; propylenes such as propano, prop[1]eno, propa[1,2]dieno, prop[1]yno, etc.; butylenes such as butano, but[1]eno, but[2]eno, buta[1,3]dieno, but[1]yno, but[2]yno, buta[1,3]diyno, etc.; and the like. Where specific levels of saturation are intended, the nomenclature alkano, alkeno and/or alkyno is used.
  • the alkylene group is (C 1 -C 6 ) or (C 1 -C 3 ) alkylene.
  • Other embodiments include straight-chain saturated alkano groups, e.g., methano, ethano, propano, butano, and the like.
  • Aryl by itself or as part of another substituent refers to a monovalent aromatic hydrocarbon group having the stated number of carbon atoms (i.e., C 5 -C 15 means from 5 to 15 carbon atoms) derived by the removal of one hydrogen atom from a single carbon atom of a parent aromatic ring system.
  • Typical aryl groups include, but are not limited to, groups derived from aceanthrylene, acenaphthylene, acephenanthrylene, anthracene, azulene, benzene, chrysene, coronene, fluoranthene, fluorene, hexacene, hexaphene, hexylene, as-indacene, s-indacene, indane, indene, naphthalene, octacene, octaphene, octalene, ovalene, penta-2,4-diene, pentacene, pentalene, pentaphene, perylene, phenalene, phenanthrene, picene, pleiadene, pyrene, pyranthrene, rubicene, triphenylene, trinaphthalene, and the like, as well as the various hydro isomers
  • Arylakl by itself or as part of another substituent refers to an acyclic alkyl radical in which one of the hydrogen atoms bonded to a carbon atom, typically a terminal or sp 3 carbon atom, is replaced with an aryl group.
  • Typical arylalkyl groups include, but are not limited to, benzyl, 2-phenylethan-1-yl, 2-phenylethen-1-yl, naphthylmethyl, 2-naphthylethan-1-yl, 2-naphthylethen-1-yl, naphthobenzyl, 2-naphthophenylethan-1-yl and the like.
  • the nomenclature arylalkanyl, arylalkenyl and/or arylalkynyl is used.
  • the arylalkyl group is (C 7 -C 30 ) arylalkyl, e.g., the alkanyl, alkenyl or alkynyl moiety of the arylalkyl group is (C 1 -C 10 ) and the aryl moiety is (C 5 -C 20 ) or, alternatively, an arylalkyl group is (C 7 -C 20 ) arylalkyl, e.g., the alkanyl, alkenyl or alkynyl moiety of the arylalkyl group is (C 1 -C 8 ) and the aryl moiety is (C 6 -C 12 ).
  • Aryloxyalkyl refers to a moiety having an aryl group and an alkyl group tethered together via an oxygen bond. Suitable aryloxyalkyl groups include phenyloxyalkylenes, such as methoxyphenyl or ethoxyphenyl.
  • Cycloalkyl by itself or as part of another substituent refers to a cyclic version of an “alkyl” group.
  • Typical cycloalkyl groups include, but are not limited to, cyclopropyl; cyclobutyls such as cyclobutanyl and cyclobutenyl; cyclopentyls such as cyclopentanyl and cycloalkenyl; cyclohexyls such as cyclohexanyl and cyclohexenyl; and the like.
  • “Cycloheteroalkyl” by itself or as part of another substituent refers to a saturated or unsaturated cyclic alkyl radical in which one or more carbon atoms (and any associated hydrogen atoms) are independently replaced with the same or different heteroatom.
  • Typical heteroatoms to replace the carbon atom(s) include, but are not limited to, N, P, O, S or Si. Where a specific level of saturation is intended, the nomenclature “cycloheteroalkanyl” or “cycloheteroalkenyl” is used.
  • Typical cycloheteroalkyl groups include, but are not limited to, groups derived from epoxides, imidazolidine, morpholine, piperazine, piperidine, pyrazolidine, pyrrolidine, quinuclidine, and the like.
  • Halogen or “Halo” by themselves or as part of another substituent, unless otherwise stated, refer to fluoro, chloro, bromo and iodo.
  • Haloalkyl by itself or as part of another substituent refers to an alkyl group in which one or more of the hydrogen atoms are replaced with a halogen.
  • haloalkyl is meant to include monohaloalkyls, dihaloalkyls, trihaloalkyls, etc. up to perhaloalkyls.
  • the expression “(C 1 -C 2 ) haloalkyl” includes fluoromethyl, difluoromethyl, trifluoromethyl, 1-fluoroethyl, 1,1-difluoroethyl, 1,2-difluoroethyl, 1,1,1-trifluoroethyl or perfluoroethyl.
  • Heteroalkyl, Heteroalkynyl, Heteroalkenyl, Heteroalkynyl by itself or as part of another substituent refer to alkyl, alkanyl, alkenyl and alkynyl radical, respectively, in which one or more of the carbon atoms (and any associated hydrogen atoms) are each independently replaced with the same or different heteroatomic groups.
  • Typical heteroatomic groups include, but are not limited to, —O—, —S—, —O—O—, —S—S—, —O—S—, —NR′—, ⁇ N—N ⁇ , —N ⁇ N—, —N ⁇ N—NR′—, —PH—, —P(O) 2 —, —O—P(O) 2 —, —S(O)—, —S(O) 2 —, —SnH 2 — and the like, where R′ is hydrogen, alkyl, substituted alkyl, cycloalkyl, substituted cycloalkyl, aryl or substituted aryl.
  • Heteroaryl by itself or as part of another substituent, refers to a monovalent heteroaromatic radical derived by the removal of one hydrogen atom from a single atom of a parent heteroaromatic ring system.
  • Typical heteroaryl groups include, but are not limited to, groups derived from acridine, arsindole, carbazole, ⁇ -carboline, benzoxazine, benzimidazole, chromane, chromene, cinnoline, furan, imidazole, indazole, indole, indoline, indolizine, isobenzofuran, isochromene, isoindole, isoindoline, isoquinoline, isothiazole, isoxazole, naphthyridine, oxadiazole, oxazole, perimidine, phenanthridine, phenanthroline, phenazine, phthalazine, pter
  • the heteroaryl group may be from 5-20 membered heteroaryl or, alternatively, from 5-10 membered heteroaryl.
  • the heteroaryl groups are those derived from thiophene, pyrrole, benzothiophene, benzofuran, indole, pyridine, quinoline, imidazole, oxazole and pyrazine.
  • Heteroarylalkyl by itself or as part of another substituent refers to an acyclic alkyl group in which one of the hydrogen atoms bonded to a carbon atom, typically a terminal or sp 3 carbon atom, is replaced with a heteroaryl group. Where specific alkyl moieties are intended, the nomenclature heteroarylalkanyl, heteroarylalkenyl and/or heteroarylalkynyl is used.
  • the heteroarylalkyl group is a 6-21 membered heteroarylalkyl, e.g., the alkanyl, alkenyl or alkynyl moiety of the heteroarylalkyl is (C 1 -C 6 ) alkyl and the heteroaryl moiety is a 5-15-membered heteroaryl.
  • the heteroarylalkyl is a 6-13 membered heteroarylalkyl, e.g., the alkanyl, alkenyl or alkynyl moiety is (C 1 -C 3 ) alkyl and the heteroaryl moiety is a 5-10 membered heteroaryl.
  • Hydroalkyl by itself or as part of another substituent refers to an alkyl group in which one or more of the hydrogen atoms are replaced with a hydroxyl substituent.
  • hydroxyalkyl is meant to include monohydroxyalkyls, dihydroxyalkyls or trihydroxyalkyls.
  • Parent aromatic Ring System refers to an unsaturated cyclic or polycyclic ring system having a conjugated ⁇ electron system.
  • parent aromatic ring system fused ring systems in which one or more of the rings are aromatic and one or more of the rings are saturated or unsaturated, such as, for example, fluorene, indane, indene, phenalene, tetrahydronaphthalene, etc.
  • Typical parent aromatic ring systems include, but are not limited to, aceanthrylene, acenaphthylene, acephenanthrylene, anthracene, azulene, benzene, chrysene, coronene, fluoranthene, fluorene, hexacene, hexaphene, hexylene, indacene, s-indacene, indane, indene, naphthalene, octacene, octaphene, octalene, ovalene, penta-2,4-diene, pentacene, pentalene, pentaphene, perylene, phenalene, phenanthrene, picene, pleiadene, pyrene, pyranthrene, rubicene, tetrahydronaphthalene, triphenylene, trinaphthalene, and the like, as well as
  • Parent Heteroaromatic Ring System refers to a parent aromatic ring system in which one or more carbon atoms (and any associated hydrogen atoms) are independently replaced with the same or different heteroatom. Typical heteroatoms to replace the carbon atoms include, but are not limited to, N, P, O, S, Si, etc. Specifically included within the definition of “parent heteroaromatic ring systems” are fused ring systems in which one or more of the rings are aromatic and one or more of the rings are saturated or unsaturated, such as, for example, arsindole, benzodioxan, benzofuran, chromane, chromene, indole, indoline, xanthene, etc.
  • Typical parent heteroaromatic ring systems include, but are not limited to, arsindole, carbazole, ⁇ -carboline, chromane, chromene, cinnoline, furan, imidazole, indazole, indole, indoline, indolizine, isobenzofuran, isochromene, isoindole, isoindoline, isoquinoline, isothiazole, isoxazole, naphthyridine, oxadiazole, oxazole, perimidine, phenanthridine, phenanthroline, phenazine, phthalazine, pteridine, purine, pyran, pyrazine, pyrazole, pyridazine, pyridine, pyrimidine, pyrrole, pyrrolizine, quinazoline, quinoline, quinolizine, quinoxaline, tetrazole, thi
  • leaving group is a group that is displaced during a reaction by a nucleophilic reagent. Suitable leaving groups include S(O) 2 Me, —SMe or halo (e.g., F, Cl, Br, I).
  • Linking group is a group that serves as an intermediate locus between two or more end groups.
  • the nature of the linking group can vary widely, and can include virtually any combination of atoms or groups useful for spacing one molecular moiety from another.
  • the linker may be an acyclic hydrocarbon bridge (e.g., a saturated or unsaturated alkyleno such as methano, ethano, etheno, propano, prop[1]eno, butano, but[1]eno, but[2]eno, buta[1,3]dieno, and the like), a monocyclic or polycyclic hydrocarbon bridge (e.g., [1,2]benzeno, [2,3]naphthaleno, and the like), a simple acyclic heteroatomic or heteroalkyldiyl bridge (e.g., —O—, —S—, —S—O—, —NH—, —PH—, —C(O)—, —C(
  • Protecting group is a group that is appended to, for example, a hydroxyl oxygen in place of a labile hydrogen atom.
  • Suitable hydroxyl protecting group(s) include esters (acetate, ethylacetate), ethers (methyl, ethyl), ethoxylated derivatives (ethylene glycol, propylene glycol) and the like that can be removed under either acidic or basic conditions so that the protecting group is removed and replaced with a hydrogen atom.
  • Greene & Wuts Protective Groups in Organic Synthesis, 3d Edition, John Wiley & Sons, Inc., New York (1999) and the references cited therein (hereinafter “Greene & Wuts”).
  • Plastics or porous membranes such as polyolefins, polystyrenes, poly(methyl)methacrylates, polyacrylonitriles, poly(vinylacetates), poly (vinyl alcohols), chlorine-containing polymers such as poly(vinyl)chloride, polyoxymethylenes, polycarbonates, polyamides, polyimides, polyurethanes, phenolics, amino-epoxy resins, polyesters, silicones, cellulose-based plastics, fluoropolymers and rubber-like plastics can all be used as supports, providing surfaces that can be modified as described herein.
  • supports such as those formed of pyrolytic carbon, parylene coated surfaces, and silylated surfaces of glass, ceramic, or metal are suitable for surface modification.
  • the method of the present invention may involve the attachment of a biologically active material to a support surface.
  • a thermally responsive nanofiber including a cross-linking agent is provided having two or more latent reactive activatable groups in the presence of a support surface.
  • the nanofiber may also include a biologically active material or a functional polymer that is reactive with a biologically active material. At least one of the latent reactive groups is activated and covalently bonded to the surface. The remaining latent reactive groups are allowed to remain in their inactive state and are later activated in order to bind a biologically active material or a functional polymer in order to attach the biologically active material to the surface of the substrate.
  • a functional polymer is a polymer having one or more functional groups that will react with a biologically active material.
  • Representative functional groups include carboxy, ester, epoxy, hydroxyl, amido, amino, thio N-hydroxy succinimide, isocyanate, anhydride, azide, aldehyde, cyanuryl chloride or phosphine groups that will react with a biologically active material
  • the biologically active material or functional polymer provided in the thermally responsive nanofiber composition may bind to a second biological material in order to attach the second biological material to the surface of the substrate through manipulation of the physical properties of the support surface via, for example, the application or removal of heat from the system.
  • a thermally responsive nanofiber including a thermally responsive polymer and cross-linking agent may be physically absorbed in or adsorbed to a suitable support surface by hydrophobic interactions.
  • at least one of the photoactivatable groups e.g., benzophenone groups
  • the photoactivatable group undergoes covalent bond formation at the support surface.
  • the photoactivatable group With the absence of abstractable hydrogens in the proximity of the remaining unbonded photoactivatable group(s), and removal of the photoactivation source, the photoactivatable group returns from an excited state to a ground state.
  • photoactivatable groups are then capable of being reactivated when a biologically active material intended for immobilization is present, and when the treated surface is exposed to another round of illumination.
  • This method can be described as a “two-step” approach, where the thermally responsive nanofiber is applied in the first step to create a latent reactive surface, and in the second step, the biologically active material is added for attachment to the activated surface.
  • the method described as a “one-step” method, provides that the thermally responsive nanofibers of the present invention are mixed together with the biologically active material to form a composition.
  • the resultant composition is used to surface modify materials in a single photoactivation step.
  • photoactivation triggers not only covalent bond formation of at least one photoactivatable group with the surface of the substrate, but also simultaneously triggers covalent bond formation with any adjacent biologically active materials residing on the surface.
  • the thermally responsive nanofiber is formed from a combination or mixture including a thermally responsive polymer, a cross-linking agent having at least two latent activatable groups, and a biologically active material. At least one of the latent reactive groups undergoes covalent bond formation at the support surface to bond the nanofiber to the surface of the substrate. The remaining latent reactive group(s) can undergo photoactivation to react with a second biologically active material. Alternatively, the biologically active material incorporated into the nanofiber can itself react with a second biologically active material to provide for further functionalization of the substrate.
  • the thermally responsive nanofibers of the present invention are used to pretreat a substrate surface prior to the application and bonding of molecules that have themselves been functionalized with latent reactive groups.
  • This method is useful in situations where a particularly difficult substrate requires maximal coating durability.
  • the number of covalent bonds formed between the substrate surface and the target molecule derivatized with latent reactive groups can typically be increased, as compared to surface modification with a desired latent reactive group-containing target molecule alone.
  • the thermally responsive surface can then be fine tuned by the application or removal of heat to the system to selectively bind and release a biological material of interest.
  • Heat can be applied to the system to transition the thermally responsive nanofiber bound to the surface from a hydrophilic state to a hydrophobic state. In a hydrophobic state at a temperature higher than LCST, the polymer chains collapse and the surface becomes hydrophobic. In this state the thermally responsive nanofiber surface may attract or repel select target molecules.
  • heat can also be removed from the system by cooling the substrate below the LCST. Once cooled, the thermally responsive nanofiber may revert back to its initial hydrophilic state, once again showing an altered affinity for a particular target molecule.
  • Suitable biologically active or target molecules for use in the present invention encompass a diverse group of materials or substances. These materials may be used in either an underivatized form or previously derivatized. Moreover, target molecules can be immobilized singly or in combination with other types of target molecules.
  • Target molecules can be immobilized to the surface after (e.g., sequentially) the surface has been primed with the thermally responsive nanofibers of the present invention. Alternatively, target molecules are immobilized during (e.g., simultaneously with) attachment of the thermally responsive nanofibers to the surface of the substrate.
  • target molecules are selected so as to confer particular desired properties to the surface and/or to the device or article bearing the surface.
  • the target molecule or material is a biologically active material.
  • Biologically active materials which may be immobilized on the surface of the nanofiber modified substrate, or alternatively, provided as a part of the nanofiber composition, generally include, but are not limited to, the following: enzymes, proteins, carbohydrates, nucleic acids, and mixtures thereof.
  • suitable target molecules, including biological materials, and the surface properties they are typically used to provide is represented by the following nonlimiting list.
  • TARGET MOLECULE FUNCTIONAL ACTIVITY Synthetic Polymers Sulfonic acid-substituted Lubricity, negatively charged surface, polyacrylamide hydrophilicity Polyacrylamide Lubricity, protein repulsion, hydrophilicity Polyethylene glycol Lubricity, cell and protein repulsion, hydrophilicity Polyethyleneimine Positively charged surface Polylactic acid Bioerodible surface Polyvinyl alcohol Lubricity, hydrophilicity Polyvinyl pyrrolidone Lubricity, hydrophilicity Quaternary amine-substituted Lubricity, positively charged surface polyacrylamide Silicone Lubricity, hydrophobicity Conductive polymeric Electric conductivity materials, e.g., polyvinylpyridine, polyacetylene, polypyrrole) Carbohydrates Alginic acid Lubricity, hydrophilicity Cellulose Lubricity, hydrophilicity, bio-degradable glucose source Chitosan Positively charged surface, hydrophilicity, hemostatsis Glycogen Hydrophilicity
  • Antithrombogenic surface antithrombin III Albumin Nonthrombogenic surface Attachment proteins/peptides Cell attachment (e.g. collagen) Enzymes Catalytic surface Extracellular matrix Cell attachment and growth proteins/peptides Growth factors, Cell growth proteins/peptides Hirudin Antithrombogenic surface Thrombolytic proteins (e.g., Thrombolytic activity streptokinase, plasmin, urokinase) Lipids Fatty acids Hydrophobicity, biocompatibility Mono-, di- and triglycerides Hydrophobicity, lubricity, bio-degradable fatty acid source Phospholipids Hydrophobicity, lubricity, bio-degradable fatty acid source Prostaglandins/leukotrienes Nonthrombogenic surface/immobilized messenger Nucleic Acids DNA Substrate for nucleases/affinity binding, genomic assay RNA Substrate for nucleases/affinity binding, genomic assay Nucleosides, nucleotides
  • thermally responsive nanofibers of the present invention can be used in a wide variety of applications including: filters, scaffolds for tissue engineering, protective clothing, reinforcement of composite materials, and sensor technologies.
  • Medical articles that can be fabricated from or coated or treated with the thermally responsive nanofibers of the present invention can include, but are not limited to, the following: catheters including urinary catheters and vascular catheters (e.g., peripheral and central vascular catheters), wound drainage tubes, arterial grafts, soft tissue patches, gloves, shunts, stents, tracheal catheters, wound dressings, sutures, guide wires and prosthetic devices (e.g., heart valves and LVADs).
  • catheters including urinary catheters and vascular catheters (e.g., peripheral and central vascular catheters), wound drainage tubes, arterial grafts, soft tissue patches, gloves, shunts, stents, tracheal catheters, wound dressings, sutures, guide wires and prosthetic devices (e.g., heart valves and LVADs).
  • urinary catheters and vascular catheters e.g., peripheral and central vascular catheters
  • wound drainage tubes e.g., arterial grafts
  • Vascular catheters which can be prepared according to the present invention include, but are not limited to, single and multiple lumen central venous catheters, peripherally inserted central venous catheters, emergency infusion catheters, percutaneous sheath introducer systems, thermodilution catheters, including the hubs and ports of such vascular catheters, leads to electronic devices such as pacemakers, defibrillators, artificial hearts, and implanted biosensors.
  • Additional articles that can be fabricated from or have a surface that can be coated or treated with the thermally responsive nanofibers of the present invention can include, but are not limited to, the following: slides, multi-well plates, Petri dishes, tissue culture slides, tissue culture plates, tissue culture flasks, cell culture devices, or column supports and/or chromatography media.
  • thermally responsive nanofibers of the present invention can be applied to a microscope slide or “chip” for biomolecule immobilization.
  • the thermally responsive nanofibers of the present invention can be applied to a surface of a cell culture device to provide a thermally responsive surface
  • TCPS tissue culture polystyrene
  • PIPAAm poly-isopropylacrylamide
  • TCPS tissue culture polystyrene
  • PIPAAm poly-isopropylacrylamide
  • the cells adhered, proliferated and differentiated in the same manner as uncoated TCPS.
  • digestive trypsin treatment is carried out to dissolve the extracellular matrix and to chelate and remove Ca ions to release the cells, which in the process lose their cell surface receptors, gap junctions and underlying extracellular matrix.
  • Another alternative for cell release is the use of cell scrapers, the mechanical use of which generates irregularly shaped tissue fragments.
  • thermo-responsive polymer coated dishes the cells are detached in a non invasive fashion only by reducing the culture temperature from 20°-32° C. at a temperature at which the polymer hydrates. In contrast to enzymatic digestion, both adhesive proteins and cell-cell junctions between the confluent cells are preserved, enabling generation of a three dimensional functional tissue that lacks any scaffold.
  • Cell sheet engineering is a unique technique that has arisen from the use of thermo-responsive polymer as a cell culture substrate.
  • PIPAAm becomes hydrophobic, promoting protein adsorption and thereby cell adhesion.
  • By lowering the temperature to 20°-32° C. cells can be released from the underlying substrate.
  • the change from hydrophobic to hydrophilic character over this transition results in the release of proteins and adherent cells from the culture substrate.
  • ECM extracellular matrix
  • the intact ECM serves as glue to layer cell sheets to form homogenous tissue grafts for example highly pulsatile cardiac tissue grafts or heterogeneous tissue grafts by layering sheets from various different cell types, for example endothelial cells and hepatocytes.
  • the cell sheets thus generated have been highly applicable to animal transplant studies. Transplant experiments have been done to compare the response of dissociated cells versus cell sheet injections. Dissociated cardiomyocytes equivalent to four cell sheets were injected into left subcutaneous dorsal tissue and four cell sheet layers obtained from low temperature lift off mediated by thermo-responsive polymer, were transplanted into the right subcutaneous tissue. The isolated cells formed a lump under the skin while the sheet transplanted site remained smooth. One week after the transplant, the respective sites were opened and cross sectional views of the right side indicated a flat square cardiac graft with no visible necrosis and connexin 43 (a gap junction marker) staining revealed the presence of numerous gap junctions.
  • the left side showed cell dense graft surface zones with central cell-void areas and only a few depositions were seen when stained for connexin 43.
  • the grafting of PIPAAm on tissue culture polystyrene and its success with the culture and harvest of various cell types has led to the development of commercially available tissue culture polystyrene dishes by Cell Seed Inc. (Tokyo, Japan).
  • the use of these surfaces completely abandons the use of trypsin when collecting cells as detachment is achieved by lowering the culture temperature. This eliminates the use of laborious pipetting, saving on both labor, time and cell/tissue damage.
  • the culture surfaces can also be functionalized by co-polymerization of PIPAAm with its carboxylate derivatized analog, 2-carboxyisopropylacrylamide (CIPAAm). Insulin was immobilized on culture surfaces by standard amide bond formation with the CIPAAm carboxylate group. The surfaces with immobilized insulin showed an increase in proliferation of bovine carotid artery endothelial (BAEC) cells even without the addition of serum.
  • the carboxyl groups on CIPPAm sequences can be used to immobilize cell adhesive sequences such as RGDS which promotes BAEC cell adhesion and proliferation without the addition of fetal bovine serum in the culture medium.
  • the culture of cells and their low temperature lift off obviates the need of using serum which has both cost and safety (prions and bovine spongiform encephalopathy) concerns regarding its use.
  • These surfaces would be useful for serum free culture of cells and cell sheets which can then be used in various tissue engineering and transplant applications.
  • the spontaneous cell sheet generation from PIPAAm-grafted TCPS is a relatively slow process, occurring gradually from the sheet periphery toward the interior. Thus, significant incubation time is required to lift up the intact, viable cell sheet completely. Rapid recovery of cell sheets is considered important to maintain biological function and viability of recovered cell sheets, as well as for practical assembly of tissue structures.
  • the rate limiting step to cell recovery is the hydration of hydrophobized PIPAAm segments interacting with the cell sheet, incorporation of a highly water permeable substrate to interface is desirable between cell sheets and the thermo-responsive surfaces.
  • pore size of a membrane is an important factor in determining the cell adhesion and growth. In general, cells do not grow on surfaces which have a pore size greater than their pseudopodium. On membranes with pore size greater than 5 ⁇ m the fibroblast adhesion and suppression was found to be greatly reduced.
  • Nanofibers produced via the process of electrospinning may have unprecedented porosity (>70%), a high surface to volume ratio, and a wide range of pore diameter distribution and high interconnectivity, all physical properties ideal for promoting cell attachment and growth. Furthermore, the nanotopography of electrospun nanofibers closely resembles the nanofibrillar and nanoporous 3D geometry of the ECM and basement membrane. The higher surface area allows for a higher percentage of cellular attachment as well as for multiple focal adhesion points on different fibers due to nano-sized fiber diameters. Because the diameters of nanofibers are orders of magnitude smaller than the size of the cells, cells are able to organize, spread or attach to adsorbed proteins at multiple focal points.
  • Electrospun nanofibers are capable of supporting a wide variety of cell types.
  • PLCL poly (L-lactic acid-co- ⁇ -caprolactone)
  • Cells attached to microfibers were round in shape and non-proliferative, whereas on nanofibers, the cells were nicely spread out and anchored on multiple fibers.
  • Elias and co-workers have reported osteoblast adhesion, proliferation, alkaline phosphatase activity and ECM secretion on carbon nanofibers increased with decreasing fiber diameter in the range of 60-200 nm.
  • Nanogrooved surfaces can induce contact guidance of human corneal epithelial cells, causing them to elongate and align their cytoskeleton along the topological features.
  • Highly porous PLLA scaffolds with nanoscale pores created using a liquid-liquid phase separation have been used for the culture of neural stem cells and were shown to have a positive effect on neurite outgrowth.
  • Recent studies show that the growth of NIH 3T3 fibroblasts and normal rat kidney cells on polyamide nanofibrillar surfaces resulted in changes in morphology, actin organization, focal adhesion assembly, fibronectin secretion and rates of cell proliferation that are more representative of fibroblast phenotype in vivo.
  • Fetal bovine chondrocytes seeded on nanofibers poly ( ⁇ -caprolactone) (PCL) scaffolds were able to maintain the chondrocytic phenotype during three weeks of culture, specifically upregulating collagen type JIB expression, indicative of mature chondrocyte phenotype.
  • PCL nanofibers poly ( ⁇ -caprolactone)
  • the nanofibers may also be functionalized using bioactive molecules. Functionalization is typically carried out by either conjugating the molecules to the surface of the nanofibers or by incorporating the bioactive molecules in the spinning solution.
  • Polyacrylic acid (PAA) grafted onto poly ( ⁇ -caprolactone-coethyl ethylene phosphate) (PCLEEP) allows for the conjugation of galactose ligand, which mediates hepatocytes attachment.
  • Hepatocytes cultured on these PCLEEP functionalized nanofiber scaffolds formed 20-100 ⁇ m spheroid aggregates that engulfed the nanofibers.
  • aminated nanofiber meshes supported a higher degree of cell adhesion and proliferation of hematopoietic stem/progenitor cells compared to aminated films.
  • conjugation of bone morphogenetic protein-2 (BMP-2) on chitosan nanofibers resulted in better proliferation, alkaline phosphatase activity and calcium deposition of osteoblastic cells.
  • the nanoscale nature of the electrospun polymeric nanofibers mimics the natural ECM.
  • ECM-like properties of the nanofibers can be used to stimulate and encourage cell proliferation and differentiation.
  • the cells are able to maintain their in vivo like morphology and function.
  • the combination of fiber composition, morphology, alignment and the capacity to incorporate bioactive molecules or growth factors helps recreate the functions of native ECM.
  • PCL Poly ( ⁇ -caprolactone) (PCL), with an average molecular weight of 80 kDa and Polystyrene (350,000 Da) were purchased from Aldrich chemicals (Milwaukee, Wis.). 0.14 g/ml solutions were prepared by dissolving 14 g of PCL or PS in 100 ml of organic solvent mixture (1:1) composed of tetrahydrofuran (Fisher Scientific) and N,N-dimethylformamide (Alfa Aesar, Ward Hill, Mass.) and mixing it well by shaking the mixture for 24 h at room temperature. The polymer solution was placed in a plastic syringe fitted with a 27G blunt needle (Strategic Applications, Inc., Libertyville, Ill.).
  • Nanofiber meshes were fabricated by electrospinning using a high voltage power supply (Gamma High Voltage Research, USA). The nanofibers were collected onto grounded aluminum foil located at a fixed distance from the needle tip. The meshes were then removed, placed in a vacuum chamber for at least 48 h to remove organic solvent residue and then stored in a dessicator. The nanofibers were evaluated with a microscope (Olympus BX 60).
  • Parameters that significantly influence the diameter, consistency and uniformity of the electrospun PCL and PS fibers were polymer concentration, applied voltage, solution feeding rate and needle-collector distance. These parameters were optimized until unbeaded and uniform fibers were spun continuously without needle clogging. Three polymer concentrations (0.10 g/ml, 0.12 g/ml, and 0.14 g/ml), two voltages (17 kv, 20 kv) and three needle-collector distances (8 cm, 12 cm, 15 cm) were investigated to obtain non-defect nanofibers. The optimized conditions are shown in Table 1.
  • FIG. 1 shows the typical SEM image of PCL nanofibers.
  • the average fiber diameter of nanofibers is, 453 ⁇ 146 nm. Highly porous structure was observed in the formulation tested. The porosity measured by a liquid displacement method was 0.90
  • thermo-responsive polymer on different culture substrates.
  • the substrates included TCPS, Thermanox coverslips (Nunc), commercially available nanofiber meshes (Surmodics Inc., Corning Inc.) and in-house PCL nanofibers.
  • the Thermanox coverslips and nanofiber inserts were dip coated in an IPA (isopropyl alcohol) solution of 20 mg/ml PIPAAm (polyisopropylacrylamide Aldrich chemicals, Mw+20-25 KDa, WI) and 0.8 mg/ml TriLite (tris[2-hydroxy-3-(4-benzoylphenoxy)propl]isocyanurate.
  • IPA isopropyl alcohol
  • PIPAAm polyisopropylacrylamide Aldrich chemicals, Mw+20-25 KDa, WI
  • TriLite tris[2-hydroxy-3-(4-benzoylphenoxy)propl]isocyanurate.
  • the pieces were dip coated by immersing in the coating solution for 10 seconds and then extracted at a speed of 0.5 cm/sec.
  • the meshes were air dried and then UV illuminated (300-400 nm, Harland Medical UVM400, MN) for 5 minutes.
  • UV illuminated 300-400 nm, Harland Medical UVM400, MN
  • Various dipping speeds, concentrations, number of dips and immerse times were tried.
  • the efficacy of the coated surfaces was tested by the attachment and detachment behavior of the BAEC cells (Lonza Biosciences, NJ, USA) at 37° C. and 20° C. respectively. Although the above mentioned conditions worked well for cell attachment and detachment, this dipping method could not coat the tissue culture formatted surfaces (for example, multi well dishes or 100 mm dishes).
  • TriLite Four formulations containing 1.0 wt % TriLite were prepared to synthesize smart polymer photoreactive nanofibers. These formulations were PS in (DMF/THF), PCL in (DMF/THF), PIPAAm in (IPA/DMF), PIPAAm-co-PEG (1%) in water.
  • the nanofibers were fabricated by the electrospinning process of Example 2. The parameters such as, polymer concentration, solvent ratio, applied voltage and needle-collector distance, were optimized until unbeaded and uniform fibers with an average diameter under 500 nm can be spun continuously without needle clogging. The optimized conditions are shown in Table 2. After drying, all the nanofibers except PS and PCL were illuminated for 5 minutes under a UV lamp (Harland Medical UVM400, Eden Prairie, Minn.).
  • PEG-PIPAAm was synthesized by free radical copolymerization of N-isopropylacrylamide (Aldrich) with poly (ethyleneglycol) methyl ether methacrylate (Mw 2,000, Aldrich) in water using ammonium persulfate (Sigma) as initiator and N,N,N′,N′-tetramethylethylenediamine (Aldrich) as a catalyst.
  • coated nanofiber meshes were completed they were examined for surface topography, protein adsorption, and contact angle. Initially they were screened in house for uniformity by microscopic examination (looking for changes in pore size, and obvious delamination or uncoated areas) and for contact angles. Comparison between bulk PIPAAm, the coated and uncoated nanofiber mesh, and the hydrophobic polystyrene core will provide evidence for surface changes. Microscopic examination of the coated nanofibers showed no obvious delamination or changes in the morphology compared to the uncoated nanofibers.
  • Coatings which passed initial screening were assessed for protein adsorption. PIPAAm surfaces at 37° C. should adsorb considerably more protein than at 25° C. because of the phase transition.
  • Coated and uncoated TCPS coverslips incubated in 1 ⁇ PBS buffer at 37° C. and 4° C. for two hours, then quickly removed and placed in a solution of 1 mg/ml BSA for 6 hours at 37° C. and 4° C. This time period should be enough for protein adsorption to occur. Following the BSA incubation, the pieces were rinsed three times with 1 ⁇ PBS and placed in HRP-labeled anti-BSA antibody (Sigma) for 30 minutes, followed by a standard rinse and HRP colorimetric assay. Pieces were considered coated with the thermo-responsive polymer if the difference in protein adsorption between 37° C. and 25° C. incubated coated pieces exceeds one standard deviation and differs significantly from that of uncoated pieces.
  • Bovine plasma FN (Biomedical Technology Inc, MA) was adsorbed onto the nanofibrillar surfaces by incubation of 10 ⁇ g/ml FN in PBS solution at 37° C. and 25° C. for 6 hours. The coated pieces were then vigorously washed with PBS for five times. They were blocked with 0.1% bovine serum albumin (BSA) in PBS for one hour and reacted with 2.0 mg/ml rabbit polyclonal anti bovine FN antibody (Biogenesis, Inc, UK) at a 1:200 dilution (final concentration, 10 ⁇ g/ml) for 2 hours at 37° C. and 25° C. respectively.
  • BSA bovine serum albumin
  • Bovine Aortic Endothelial Cells BAEC and T47-D cells were pre-cultured in 75 cm 2 flasks in DMEM-F12+10% FBS. The cells were trypsinized and plated on PIPAAm coated nanofibrillar and TCPS surfaces. The cells were also plated on commercially available PIPAAm coated TCPS surfaces (Cell Seed Inc). Both cell lines were plated at a density of 100,000 cells/well in a 6-well PIPAAm coated dishes. Bare TCPS and Cell Seed surfaces were used as control surfaces and similar numbers of cells were plated on them. The cells were cultured for a period of 48 hours in a humidified atmosphere with 5% C02 at 37° C.
  • nanofibrillar surfaces form more in vivo like morphologies. These surfaces are also permissive for epithelial cells to undergo morphogenesis.
  • our coating on smart polymer surfaces does not interfere with the nanofibrillar properties of the matrix and cells still undergo morphogenesis or form more in vivo like structures in addition to being detached by mere temperature reduction.
  • T47-D breast epithelial cells were cultured on nanofibrillar and flat surfaces coated with PIPAAm/TriLite.
  • the controls were bare nanofibers and TCPS.
  • the cells were cultured in DMEM+10% fetal bovine serum (FBS) in an atmosphere of 5% CO 2 , 95% air at 37° C.
  • FBS fetal bovine serum
  • This particular cell line has been selected as it has shown to demonstrate tubular and spheroidal structures under conditions that promote three dimensional interactions with collagen or matrigel.
  • Phalloidin Alexa Fluor 594 (1:500, Molecular Probes, OR
  • the cells were rinsed three times with PBS and observed under an inverted fluorescent microscope (Zeiss Axiovert 200M). Phalloidin binds to filamentous actin (F-actin) and provides visualization of cytoskeletal organization of the cells. After 5 days in culture, a mixed population of spheroids and tubular cells was observed on nanofibers. By day 8, multicellular spheroids were dominant although some tubules still persisted. In contrast, the growth of T47-D cells on flat surfaces showed a monolayer with a group of stress fibers.
  • thermo-responsive polymer does not affect the nanofibrillar topology and hence morphogenesis of T47-D cells or more in vivo like cells can be obtained on these surfaces by mere reduction of temperature.
  • the second set of cells was grown to confluency for about 5-10 days at 37° C. The cells were then moved to room temperature for about 15-40 minutes. The detached cell sheet was gently removed with the help of a 10.0 ml pipette to a fresh tissue culture surface. The cells were allowed to settle down and were then fixed with 4% paraformaldehyde after 30 minutes incubation at 37° C. Replated cells were stained with phalloidin F-actin to show that the advantage of growing cells on thermo-responsive nanofibrillar surfaces as opposed to flat thermo-responsive surfaces is the ability to achieve and retain in vivo like morphology (D).
  • FIG. 7A shows the T47-D cells cultured on PIPAAm/TriLite coated nanofibers for a period of 10 days and stained with Phalloidin F-actin. Note the presence of multicellular spheroids and the peripheral organization of actin filaments.
  • a magnified image (400 ⁇ m) of the spheroid of FIG. 7B shows the lumen extending through the spheroid.
  • T47-D cells cultured on PIPAAm/TriLite coated TCPS for period of 10 days were also fixed and stained for phalloidin F-actin. Note the spread out morphology and organization of stress fibers in the cells of FIG. 7C . T47-D cells lifted up through temperature reduction were replated on fresh nanofibers.
  • FIG. 7D shows that replated T47-D cells maintain their tubular and spheroidal morphology and peripheral organization of actin (200 ⁇ m).
  • Replated cell sheets were also analyzed for conexxin 43 expression which is considered to be a major component of gap junctional channel.
  • BAEC cells were plated at a density of 50,000 cells/22 mm well. The cells were cultured until confluency and then lifted up by moving the dish to 20° C. for 15 minutes. The sheets were transferred onto fresh nanofibrillar surfaces with the help of a 10 ml pipette and the curled up edges were uncurled by adding a drop of medium onto the sheet. The sheet was then transferred to the 5% CO2 humidified incubator at 37° C. and were allowed to attach. Thirty minutes later the cells were fixed with 4% paraformaldehyde and stained with 1:1000 dilution of anti connexin 43 (Sigma). Staining for Connexin 43 showed diffused expression of connexin 43 through out the entire sheet suggesting the presence of intact gap junctions ( FIG. 8 ).

Abstract

A stimuli responsive nanofiber that includes a stimuli responsive polymer, such as a thermally responsive polymer, and a cross-linking agent having at least two latent reactive activatable groups. The nanofiber may also include a biologically active material or a functional polymer. The stimuli responsive nanofiber can be used to modify the surface of a substrate. When the nanofiber includes a thermally responsive polymer, the physical properties of the surface can be controlled by controlling the temperature of the system, thus controlling the ability of the surface to bind to a biologically active material of interest.

Description

    TECHNICAL FIELD
  • The present invention generally relates to stimuli responsive nanofibers and stimuli responsive nanofiber modified surfaces. More particularly, the present invention is directed to nanofibers including a thermally responsive polymer, a multi-functional cross-linking agent, and optionally a biologically active material or a functional polymer that is reactive with a biologically active material. The stimuli responsive nanofibers can be used to modify a surface of a substrate, such as a cell culture device.
  • BACKGROUND
  • Nanofibers are being considered for a variety of applications because of their unique properties including high surface area, small fiber diameter, layer thinness, high permeability, and low basis weight. More attention has been focused on functionalized nanofibers having the capability of incorporating active chemistry, especially in biomedical applications such as wound dressing, biosensors and scaffolds for tissue engineering.
  • Nanofibers may be fabricated by electrostatic spinning (also referred to as electrospinning). The technique of electrospinning of liquids and/or solutions capable of forming fibers, is well known and has been described in a number of patents, such as, for example, U.S. Pat. Nos. 4,043,331 and 5,522,879. The process of electrospinning generally involves the introduction of a solution or liquid into an electric field, so that the solution or liquid is caused to produce fibers. These fibers are generally drawn to a conductor at an attractive electrical potential for collection. During the conversion of the solution or liquid into fibers, the fibers harden and/or dry. This hardening and/or drying may be caused by cooling of the liquid, i.e., where the liquid is normally a solid at room temperature; by evaporation of a solvent, e.g., by dehydration (physically induced hardening); or by a curing mechanism (chemically induced hardening).
  • The process of electrostatic spinning has typically been directed toward the use of the fibers to create a mat or other non-woven material, as disclosed, for example, in U.S. Pat. No. 4,043,331. Nanofibers ranging from 50 nm to 5 μm in diameter can be electrospun into a nonwoven or an aligned nanofiber mesh. Due to the small fiber diameters, electrospun textiles inherently possess a very high surface area and a small pore size. These properties make electrospun fabrics potential candidates for a number of applications including: membranes, tissue scaffolding, and other biomedical applications.
  • Nanofibers can be used to modify the surface of a substrate to achieve a desired surface characteristic. Most nanofiber surfaces have to be engineered to obtain the ability to immobilize biomolecules. Surface modification of synthetic biomaterials, with the intent to improve biocompatibility, has been extensively studied, and many common techniques have been considered for polymer nanofiber modification. For example, Sanders et al in “Fibro-Porous Meshes Made from Polyurethane Micro-Fibers: Effects of Surface Charge on Tissue Response” Biomaterials 26, 813-818 (2005) introduced different surface charges on electrospun polyurethane (PU) fiber surfaces through plasma-induced surface polymerization of negatively or positively charged monomers. The surface charged PU fiber mesh was implanted in rat subcutaneous dorsum for 5 weeks to evaluate tissue compatibility, and it was found that negatively charged surfaces may facilitate vessel ingrowth into the fibroporous mesh biomaterials. Ma et al. in “Surface Engineering of Electrospun Polyethylene Terephthalate (PET) Nanofibers Towards Development of a New Material for Blood Vessel Engineering” Biomaterials 26, 2527-2536 (2005) conjugated gelatin onto formaldehyde pretreated polyethylene terephthalate (PET) nanofibers through a grafted polymethacrylic acid spacer and found that the gelatin modification improved the spreading and proliferation of endothelial cells (ECs) on the PET nanofibers, and also preserved the EC's phenotype. Chua et al. in “Stable Immobilization of Rat Hepatocyte Spheroids on Galactosylated Nanofiber Scaffold” Biomaterials 26, 2537-2547 (2005) introduced galactose ligand onto poly(e-caprolactone-co-ethyl ethylene phosphate) (PCLEEP) nanofiber scaffold via covalent conjugation to a poly(acrylic acid) spacer UV-grafted onto the fiber surface. Hepatocyte attachment, ammonia metabolism, albumin secretion and cytochrome P450 enzymatic activity were investigated on the 3-D galactosylated PCLEEP nanofiber scaffold as well as the functional 2-D film substrate.
  • SUMMARY
  • The methods and techniques summarized above are costly, complicated, or material specific. Thus, there is a need for a surface modification approach that is more general and easy to use and can be applied under mild conditions to a wide variety of nanofibers.
  • According to one embodiment, the present invention is a stimuli responsive nanofiber including a stimuli responsive polymer. One example of a stimuli responsive nanofiber is a thermally responsive nanofiber including a thermally responsive polymer. In either of these embodiments, the stimuli responsive nanofiber may include a cross-linking agent having at least two latent reactive activatable groups. In use, photochemically, electrochemically or thermally latent reactive groups will form covalent bonds when subjected to a source of energy. Suitable energy sources include radiation, electrical and thermal energy. In some embodiments, the radiation energy is visible, ultraviolet, infrared, x-ray or microwave electromagnetic radiation.
  • The cross-linking agent may have at least two latent reactive activatable groups. These latent reactive groups may be the same or may be different. For example, all of the latent reactive groups may be photochemically reactive groups. Alternatively, in other embodiments of the invention the cross-linking agent may include both photochemically and thermally reactive groups. Further, the cross-linking agent may be monomeric or polymeric materials or may be a mixture of both monomeric and polymeric materials.
  • According to a further embodiment of the present invention, the thermally responsive polymer is poly(isopropylacrylamide) as well as derivatives of poly(isopropylacrylamide) such as graft copolymer derivatives with polyethylene glycol derivatives.
  • According to another embodiment, the present invention is a method of treating a surface of a substrate including the steps of combining a stimuli responsive polymer, such as a thermally responsive polymer, and a cross-linking agent having at least two latent reactive activatable groups; forming at least one nanofiber from the combined mixture; contacting the surface with the nanofiber; and forming a bond between the nanofiber and the surface.
  • According to another embodiment, the present invention is a surface coating for a surface of an article. The surface coating includes a stimuli responsive nanofiber including a nanofiber coated with a stimuli responsive polymer, such as a thermally responsive polymer, and a cross-linking agent having at least two latent reactive activatable groups. Optionally, the coated nanofiber or the coated surface may include a biologically active material or, alternatively, a functional polymer.
  • According to yet another embodiment, the present invention is an article including a surface coating having a thermally responsive nanofiber. According to a further embodiment, the thermally responsive nanofiber includes a thermally responsive polymer and a cross-linking agent having at least two latent reactive activatable groups.
  • According to still yet another embodiment, the present invention is a cell culture device including a surface coating having a thermally responsive nanofiber. The thermally responsive nanofiber includes a thermally responsive polymer, a cross-linking agent having at least two latent reactive activatable groups, and a biologically active material.
  • According to other embodiments of the present invention, the stimuli responsive nanofiber may have a diameter ranging from 1 to 100 microns and still other embodiments may have a diameter ranging from 1 nm to 1000 nm. The stimuli responsive nanofiber may have an aspect ratio in a range of about at least 10 to at least 100.
  • According to yet a further embodiment of the present invention, the thermally responsive nanofiber has first physical property at a first predetermined temperature range and a second physical property at a second predetermined temperature range. The thermally responsive nanofiber is capable of transitioning from a first physical property to a second physical property upon the application or removal of heat to or from the system
  • Various modifications and additions can be made to the exemplary embodiments discussed without departing from the scope of the present invention. For example, while the embodiments described above refer to particular features, the scope of this invention also includes embodiments having different combinations of features and embodiments that do not include all of the described features. Accordingly, the scope of the present invention is intended to embrace all such alternatives, modifications, and variations as fall within the scope of the claims, together with all equivalents thereof.
  • DESCRIPTION OF THE DRAWINGS
  • FIG. 1 is an electronic image of a polycaprolactone nanofiber described in Example 1.
  • FIG. 2 is an electronic image of a polyisopropylacrylamide nanofiber described in Example 3.
  • FIGS. 3 and 4 illustrate protein absorption profiles of polyisopropylacrylamide coated polystyrene and polyisopropylacrylamide nanofibers described in Example 4.
  • FIGS. 5 and 6 are electronic images of cell lift up times from various surfaces described in Example 5.
  • FIG. 7 is an electronic image of T47-D cells cultured on nanofiber and flat surfaces.
  • FIG. 8 is an electronic image of replated BAEC cells.
  • DETAILED DESCRIPTION
  • Stimuli responsive or “smart” materials are materials that have one or more properties that can be altered in a controlled fashion by the application of external stimuli, such as stress, temperature, moisture, pH, applied electric or magnetic fields, ionic strength, or biomolecules such as glucose or antigens. Representative stimuli responsive materials and polymers as well as their physical characteristic are reported by Gil et al., “Stimuli-responsive polymers and their bioconjugates,” Prog. Polym. Sci., 29, 1173-1222 (2004) which is incorporated by reference herein. A thermally responsive polymer is one example of these materials. A thermally responsive material is a material in which a physical property is altered in response to a change in temperature in the surrounding environment or system. A thermally responsive polymer may change from a hydrophilic state to hydrophobic state when the temperature of the system or its surroundings rises above a lower critical solution temperature (LCST). When in a hydrophilic state, the polymer chains become swollen. Conversely, in a hydrophobic state, the polymer chains collapse, and the polymer becomes insoluble in water. In most cases, the process can be reversible.
  • One embodiment of the present invention is directed to a thermally responsive nanofiber. The thermally responsive nanofiber can be used to modify a surface of a substrate to provide a functionalized surface. More particularly, the thermally responsive nanofiber can be used to provide a thermally responsive surface on a substrate. The physical property of the thermally responsive nanofiber modified surface of the substrate changes in response to a change in temperature in the system. Biologically active materials can be immobilized on the nanofiber modified surface by reacting with the functional groups accessible or exposed on the surface of the substrate. Typically, the biologically active materials retain all or a portion of their bioactivity after having been immobilized on the thermally responsive nanofiber modified surface. The ability of biologically active materials to bond with the surface of the substrate can be affected depending on the physical state of the modified surface. Thus, by controlling the temperature of the modified surface, the ability to bind to a biological material can be controlled.
  • According to one embodiment of the present invention the thermally responsive nanofiber includes a thermally responsive polymer, a biologically active material, and a cross-linking agent having at least two latent reactive activatable groups. The thermally responsive nanofiber can be used to modify the surface of a substrate by bonding the nanofiber to the surface by the formation of a covalent bond between the surface of the substrate and the nanofiber. At least one of the latent reactive activatable groups undergoes activation when subjected to a suitable energy source to form a covalent bond between the surface of the substrate and the thermally responsive nanofiber. The remaining latent reactive group(s) are left accessible or exposed on the surface of the substrate. The biologically active material included in the nanofiber or the accessible or exposed latent reactive groups on the surface may be used for further surface modification of the substrate.
  • A number of processing techniques such as drawing, template synthesis, phase separation, self-assembly or electrospinning have been used to prepare nanofibers.
  • For example, a thermally responsive nanofiber can be formed by electrospinning a fiber-forming combination that includes a thermally responsive polymer, a biologically active material, and a cross-linking agent having at least two latent reactive activatable groups. Electrospinning generally involves the introduction of a polymer or other fiber-forming solution or liquid into an electric field, so that the solution or liquid is caused to produce fibers. When a strong electrostatic field is applied to a fiber-forming combination held in a syringe with a capillary outlet, a pendant droplet of the fiber-forming mixture from the capillary outlet is deformed into a Taylor cone. When the voltage surpasses a threshold value, the electric forces overcome the surface tension on the droplet, and a charged jet of the solution or liquid is ejected from the tip of the Taylor cone. The ejected jet then moves toward a collecting metal screen that acts as a counterelectrode having a lower electrical potential. The jet is split into small charged fibers or fibrils and any solvent present evaporates leaving behind a nonwoven fabric mat formed on the screen.
  • In one embodiment, electrostatically spun fibers can be produced having very thin diameters. Parameters that influence the diameter, consistency, and uniformity of the electrospun fibers include the thermally responsive polymer, the molecular weight of the polymer; the cross-linker concentration (loading) in the fiber-forming mixture, the flow rate of the polymer solution, the applied voltage, and the needle collector distance. According to one embodiment of the present invention, a stimuli responsive nanofiber has a diameter ranging from about 1 nm to about 100 μm. In other embodiments, the stimuli responsive nanofiber has a diameter in a range of about 1 nm to about 1000 nm. Further, the nanofiber may have an aspect ratio in a range of about at least 10 to about at least 100. It will be appreciated that, because of the very small diameter of the fibers, the fibers have a high surface area per unit of mass. This high surface area to mass ratio permits fiber-forming material solutions to be transformed from solvated fiber-forming materials to solid nanofibers in fractions of a second.
  • The stimuli responsive polymer used to form the nanofiber may be selected from any stimuli responsive, fiber-forming material that is compatible with the cross-linking agent. In one embodiment, a selected thermally responsive polymer should be capable of undergoing a rapid change from a first physical property to a second physical property when the temperature of the system has risen above a lower critical solution temperature. Exemplary thermally responsive, fiber forming polymers include, but are not limited to, poly(isopropylacrylamide) and mixtures and copolymers thereof. Other thermally responsive polymers include random copolymers of 2-(2-methoxyethoxy)ethyl methacrylate and oligo(ethylene glycol) methacrylate.
  • According to one embodiment of the present invention, the thermally responsive polymer is poly(isopropylacrylamide). Poly(isopropylacrylamide) changes from a primarily hydrophobic state to a primarily hydrophilic state upon reaching a lower critical solution temperature of approximately 20 to 32° C. Poly-N-isopropylacrylamide (PIPAAm) has been one of the most studied thermo-responsive polymer not only because it displays a low critical solution temperature (LCST) of around 32° C., close to body temperature, but also because its LCST is relatively insensitive to environmental conditions. Slight variations of pH, concentration or chemical environment affect the LCST by only a few degrees. The main mechanism of PIPAAm's aqueous phase separation is the thermally induced release of water molecules bound to polymer isopropyl side groups, resulting in intra- and intermolecular hydrophobic interactions between isopropyl groups above the LCST.
  • The inclusion of cross-linking agents within the composition forming the thermally responsive nanofiber, allows the thermally responsive nanofiber to be compatible with a wide range of support surfaces. The latent reactive cross-linking agents can be used alone or in combination with other materials to provide a desired surface characteristic.
  • Suitable cross-linking agents include either monomeric (small molecule materials) or polymeric materials having at least two latent reactive activatable groups that are capable of forming covalent bonds with other materials when subjected to a source of energy such as radiation, electrical or thermal energy. In general, latent reactive activatable groups are chemical entities that respond to specific applied external energy or stimuli to generate active species with resultant covalent bonding to an adjacent chemical structure. Latent reactive groups are those groups that retain their covalent bonds under storage conditions but that form covalent bonds with other molecules upon activation by an external energy source. In some embodiments, latent reactive groups form active species such as free radicals. These free radicals may include nitrenes, carbine or excited states of ketones upon absorption of externally applied electric, electromagnetic or thermal energy. Various examples of known latent reactive groups are reported in U.S. Pat. Nos. 4,973,493; 5,258,041; 5,563,056; 5,637,460; or 6,278,018.
  • Eight commercially available multifunctional photocrosslinkers based on trichloromethyl triazine are available either from Aldrich Chemicals, Produits Chimiques Auxiliaires et de Syntheses, (Longjumeau, France), Shin-Nakamara Chemical, Midori Chemicals Co., Ltd. or Panchim S.A. (France). The eight compounds include 2,4,6-tris(trichloromethyl)-1,3,5 triazine, 2-(methyl)-4,6-bis(trichloromethyl)-1,3,5-triazine, 2-(4-methoxynaphthyl)-4,6-bis(trichloromethyl)-1,3,5-triazine, 2-(4-ethoxynaphthyl)-4,6-bis(trichloromethyl)-1,3,5-triazine, 4-(4-carboxylphenyl)-2,6-bis(trichloromethyl)-1,3,5-triazine, 2-(4-methoxyphenyl)-4,6-bis(trichloromethyl)-1,3,5-triazine, 2-(1-ethen-2-2′-furyl)-4,6-bis(trichloromethyl)-1,3,5-triazine and 2-(4-methoxystyryl)-4,6-bis(trichloromethyl)-1,3,5-triazine.
  • In some embodiments, the latent reactive groups are the same, while in other embodiments the latent reactive groups may be different. For example, the latent reactive groups may be two different groups that are both activated by radiation. In other embodiments one latent reactive group may by activated by radiation while another latent reactive group may be activated by heat. Suitable cross-linking agents include bi-, tri- and multi-functional monomeric and polymeric materials.
  • Latent reactive groups that are reactive to thermal or heat energy include a variety of reactive moieties and may include known compounds that decompose thermally to form reactive species that will then form covalent bonds. The covalent bonds allow the cross-linking to bind to adjacent materials. Suitable thermally-reactive groups typically have a pair of atoms having a heat sensitive or labile bond. Heat labile bonds include oxygen-oxygen bonds such as peroxide bonds, nitrogen-oxygen bonds, and nitrogen-nitrogen bonds. Such bonds will react or decompose at temperatures in a range of not more than 80-200° C.
  • Both thermally generated carbenes and nitrenes undergo a variety of chemical reactions, including carbon bond insertion, migration, hydrogen abstraction, and dimerization. Examples of carbene generators include diazirines and diazo-compounds. Examples of nitrene generators include aryl azides, particularly perfluorinated aryl azides, acyl azides, and triazolium ylides. In addition, groups that upon heating form reactive triplet states, such as dioxetanes, or radical anions and radical cations may also be used to form the thermally-reactive group.
  • In one embodiment the thermally-reactive group of the cross-linking agent includes a peroxide —(O—O)— group. Thermally-reactive peroxide-containing groups include, for example, thermally-reactive diacyl peroxide groups, thermally-reactive peroxydicarbonate groups, thermally-reactive dialkylperoxide groups, thermally-reactive peroxyester groups, thermally-reactive peroxyketal groups, and thermally-reactive dioxetane groups.
  • Dioxetanes are four-membered cyclic peroxides that react or decompose at lower temperatures compared to standard peroxides due to the ring strain of the molecules. The initial step in the decomposition of dioxetanes is cleavage of the O—O bond, the second step breaks the C—C bond creating one carbonyl in the excited triplet state, and one in an excited singlet state. The excited triplet state carbonyl can extract a hydrogen from an adjacent material, forming two radical species, one on the adjacent material and one on the carbon of the carbonyl with the oxygen and will form a new covalent bond between the thermally reactive dioxetane and the adjacent material.
  • Representative thermally reactive moieties are reported in US 20060030669 and other representative thermal latent reactive groups are reported in U.S. Pat. No. 5,258,041. Both of these documents are hereby incorporated by reference.
  • Latent reactive groups that are reactive to electromagnetic radiation, such as ultraviolet or visible radiation, are typically referred to as photochemical reactive groups.
  • The use of latent reactive activatable species in the form of latent reactive activatable aryl ketones is useful. Exemplary latent reactive activatable aryl ketones include acetophenone, benzophenone, anthraquinone, anthrone, anthrone-like heterocycles (i.e., heterocyclic analogs of anthrone such as those having N, O, or S in the 10-position), and their substituted (e.g., ring substituted) derivatives. Examples of aryl ketones include heterocyclic derivatives of anthrone, including acridone, xanthone, and thioxanthone, and their ring substituted derivatives. In particular, thioxanthone, and its derivatives, having excitation energies greater than about 360 nm are useful.
  • The functional groups of such ketones are suitable since they are readily capable of undergoing an activation/inactivation/reactivation cycle. Benzophenone is an exemplary photochemically reactive activatable group, since it is capable of photochemical excitation with the initial formation of an excited singlet state that undergoes intersystem crossing to the triplet state. The excited triplet state can insert into carbon-hydrogen bonds by abstraction of a hydrogen atom (from a support surface, for example), thus creating a radical pair. Subsequent collapse of the radical pair leads to formation of a new carbon-carbon bond. If a reactive bond (e.g., carbon-hydrogen) is not available for bonding, the ultraviolet light-induced excitation of the benzophenone group is reversible and the molecule returns to ground state energy level upon removal of the energy source. Photochemically reactive activatable aryl ketones such as benzophenone and acetophenone are of particular importance inasmuch as these groups are subject to multiple reactivation in water and hence provide increased coating efficiency.
  • In some embodiments of the invention, photochemically reactive cross-linking agents may be derived from three different types of molecular families. Some families include one or more hydrophilic portions, i.e., a hydroxyl group (that may be protected), amines, alkoxy groups, etc. Other families may include hydrophobic and amphiphilic portions. In one embodiment, the family has the formula:

  • L-((D-T-C(R1)(XP)CHR2GR3C(═O)R4))m.
  • L is a linking group. D is O, S, SO, SO2, NR5 or CR6R7. T is (—CH2—)x, (—CH2CH2—O—)x, (—CH2CH2CH2—O—)x or (—CH2CH2CH2CH2—O—)x. R1 is a hydrogen atom, an alkyl, alkyloxyalkyl, aryl, aryloxyalkyl or aryloxyaryl group. X is O, S, or NR8R9. P is a hydrogen atom or a protecting group, with the proviso that P is absent when X is NR8R9. R2 is a hydrogen atom, an alkyl, alkyloxyalkyl, aryl, aryloxylalkyl or aryloxyaryl group. G is O, S, SO, SO2, NR10, (CH2)t—O— or C═O. R3 and R4 are each independently an alkyl, aryl, arylalkyl, heteroaryl, or a heteroarylalkyl group or when R3 and R4 are tethered together via (—CH2—)q, (—CH2—)rC═O(—CH2—)s, (—CH2—)rS(—CH2—)s, (—CH2—)rS═O(—CH2—)s, (—CH2—)rS(O)2(—CH2—)s, or (—CH2—)rNR(—CH2—)s. R5 and R10 are each independently a hydrogen atom or an alkyl, aryl, or arylalkyl group. R6 and R7 are each independently a hydrogen atom, an alkyl, aryl, arylalkyl, heteroaryl or heteroarylalkyl group. R8 and R9 are each independently a hydrogen atom, an alkyl, aryl, or arylalkyl group, R is a hydrogen atom, an alkyl group or an aryl group, q is an integer from 1 to about 7, r is an integer from 0 to about 3, s is an integer from 0 to about 3, m is an integer from 2 to about 10, t is an integer from 1 to about 10 and x is an integer from 1 to about 500.
  • In one embodiment, L is a branched or unbranched alkyl chain having between about 2 and about 10 carbon atoms.
  • In another embodiment, D is an oxygen atom (O).
  • In still another embodiment, T is (—CH2—)x or (—CH2CH2—O—)x and x is 1 or 2.
  • In still yet another embodiment, R1 is a hydrogen atom.
  • In yet another embodiment, X is an oxygen atom, O, and P is a hydrogen atom.
  • In another embodiment, R2 is a hydrogen atom.
  • In still another embodiment, G is an oxygen atom, O.
  • In still yet another embodiment, R3 and R4 are each individually aryl groups, which can be further substituted, and m is 3.
  • In one particular embodiment, L is
  • Figure US20100255581A1-20101007-C00001
  • D is O, T is (—CH2—)x, R1 is a hydrogen atom, X is O, P is a hydrogen atom, R2 is a hydrogen atom, G is O, R3 and R4 are phenyl groups, m is 3 and x is 1.
  • In yet another particular embodiment, L is (—CH2—)y, D is O, T is (—CH2—)z, R1 is a hydrogen atom, X is O, P is a hydrogen atom, R2 is a hydrogen atom, G is O, R3 and R4 are phenyl groups, m is 2, x is 1 and y is an integer from 2 to about 6, and in particular, y is 2, 4 or 6.
  • In certain embodiments, x is an integer from about 1 to about 500, more particularly from about 1 to about 400, from about 1 to about 250, from about 1 to about 200, from about 1 to about 150, from about 1 to about 100, from about 1 to about 50, from about 1 to about 25 or from about 1 to about 10.
  • In another embodiment, the family has the formula:

  • L-((T-C(R1)(XP)CHR2GR3C(═O)R4))m,
  • and L, T, R1, X, P, R2, G, R3, R4, R8, R9, R10, R, q, r, s, m, t and x are as defined above.
  • In one embodiment, L has a formula according to structure (I):
  • Figure US20100255581A1-20101007-C00002
  • A and J are each independently a hydrogen atom, an alkyl group, an aryl group, or together with B form a cyclic ring, provided when A and J are each independently a hydrogen atom, an alkyl group, or an aryl group then B is not present, B is NR11, O, or (—CH2—)z, provided when A, B and J form a ring, then A and J are (—CH2—)z or C═O, R11 is a hydrogen atom, an alkyl group, an aryl group or denotes a bond with T, each z independently is an integer from 0 to 3 and provided when either A or J is C═O, then B is NR11, O, or (—CH2—)z and z must be at least 1.
  • In another embodiment, T is —CH2—.
  • In another embodiment, the family has the formula: L-((GTZR3C(═O)R4))m, and L, T, G, R3, R4, R10, R, q, r, s, m, t and x are as defined above. Z can be a C═O, COO or CONH when T is (—CH2—)x.
  • In one embodiment, L has a formula according to structure (I):
  • Figure US20100255581A1-20101007-C00003
  • and A, B, J, R11, and z are as defined above.
  • In another embodiment, L has a formula according to structure (II):
  • Figure US20100255581A1-20101007-C00004
  • R12, R13, R14, R15, R16, R17 are each independently a hydrogen atom, an alkyl or aryl group or denotes a bond with T, provided at least two of R12, R13, R14, R15, R16, R17 are bonded with T and each K, independently is CH or N.
  • In another embodiment, the family has the formula:

  • L-((TGQR3C(═O)R4))m,
  • L, G, R3, R4, R10, R, q, r, s, m, t and x are as defined above. T is (—CH2—)x, (—CH2CH2—O—)x, (—CH2CH2CH2—O—)x, (—CH2CH2CH2CH2—O—)x or forms a bond. Q is (—CH2—)p, (—CH2CH2—O—)p, (—CH2CH2CH2—O—)p or (—CH2CH2CH2CH2—O—)p and p is an integer from 1 to about 10.
  • In one embodiment, L has a formula according to structure (I):
  • Figure US20100255581A1-20101007-C00005
  • A, B, J, R11, and z are as defined above.
  • In another embodiment, L has a formula according to structure (II):
  • Figure US20100255581A1-20101007-C00006
  • R12, R13, R14, R15, R16, R17 are each independently a hydrogen atom, an alkyl or aryl group or denotes a bond with T, provided at least two of R12, R13, R14, R15, R16, R17 are bonded with T and each K, independently is CH or N.
  • In still yet another embodiment, compounds of the present invention provide that R3 and R4 are both phenyl groups and are tethered together via a CO, a S or a CH2.
  • In yet another embodiment, compounds of the present invention provide when R3 and R4 are phenyl groups, the phenyl groups can each independently be substituted with at least one alkyloxyalkyl group, such as CH3O—(CH2CH2O—)n—, or CH3O(—CH2CH2CH2O—)n— a hydroxylated alkoxy group, such as HO—CH2CH2O—, HO(—CH2CH2O—)n— or HO(—CH2CH2CH2O—)n—, etc. wherein n is an integer from 1 to about 10.
  • In another embodiment the family has the formula:

  • L-(((-CH2—)xxC(R1)((G)R3C(═O)R4)2)m.
  • L, each R, R1, each G, each R3, each R4, each R10, each q, each r, each s, each t and m are as defined above and xx is an integer from 1 to about 10.
  • In one embodiment, L has a formula according to structure (I):
  • Figure US20100255581A1-20101007-C00007
  • A, B, J, R11, and z are as defined above.
  • In another embodiment, A and B are both hydrogen atoms.
  • In still another embodiment, xx is 1.
  • In yet another embodiment, R1 is H.
  • In still yet another embodiment, G is (—CH2—)tO— and t is 1.
  • In another embodiment, R3 and R4 are each individually aryl groups.
  • In still yet another embodiment, xx is 1, R1 is H, each G is (—CH2—)tO—, t is 1 and each of R3 and R4 are each individually aryl groups.
  • In another embodiment of the invention, the family has the formula:

  • L-((-C(R1)(XP)CHR2GR3C(═O)R4)m.
  • L, R, R1, R2, R3, R4, R8, R9, R10, X, P, G, q, r, s, t, and m are as defined above.
  • In one embodiment, L is
  • Figure US20100255581A1-20101007-C00008
  • and R20 and R21 are each individually a hydrogen atom, an alkyl group or an aryl group.
  • In another embodiment, R1 is H.
  • In still another embodiment, wherein X is O.
  • In yet another embodiment, P is H.
  • In still yet another embodiment, R2 is H.
  • In another embodiment, G is (—CH2—)tO— and t is 1.
  • In still another embodiment, R3 and R4 are each individually aryl groups.
  • In yet another embodiment, R1 is H, X is O, P is H, R2 is H, G is (—CH2—)tO—, t is 1, R3 and R4 are each individually aryl groups and R20 and R21 are both methyl groups.
  • In yet another embodiment, the present invention provides a family of compounds having the formula:

  • L-((GR3C(═O)R4))m,
  • L is a linking group; G is O, S, SO, SO2, NR10, (CH2)t—O— or C═O; R3 and R4 are each independently an alkyl, aryl, arylalkyl, heteroaryl, or an heteroarylalkyl group or when R3 and R4 are tethered together via (—CH2—)q, (—CH2—)rC═O(—CH2—)s, (—CH2—)rS(—CH2—)s, (—CH2—)rS═O(—CH2—)s or (—CH2—)rS(O)2(—CH2—)s, (—CH2—)rNR(—CH2—)s; R10 is a hydrogen atom or an alkyl, aryl, or an arylalkyl group; R is a hydrogen atom, an alkyl or an aryl group; q is an integer from 1 to about 7; r is an integer from 0 to about 3; s is an integer from 0 to about 3; m is an integer from 2 to about 10; and t is an integer from 1 to about 10.
  • In one embodiment, L is
  • Figure US20100255581A1-20101007-C00009
  • In another embodiment, G is C═O.
  • In still another embodiment, R3 and R4 are each individually aryl groups.
  • In yet another embodiment, G is C═O and R3 and R4 are each individually aryl groups.
  • “Alkyl” by itself or as part of another substituent refers to a saturated or unsaturated branched, straight-chain or cyclic monovalent hydrocarbon radical having the stated number of carbon atoms (i.e., C1-C6 means one to six carbon atoms) that is derived by the removal of one hydrogen atom from a single carbon atom of a parent alkane, alkene or alkyne. Typical alkyl groups include, but are not limited to, methyl; ethyls such as ethanyl, ethenyl, ethynyl; propyls such as propan-1-yl, propan-2-yl, cyclopropan-1-yl, prop-1-en-1-yl, prop-1-en-2-yl, prop-2-en-1-yl, cycloprop-1-en-1-yl; cycloprop-2-en-1-yl, prop-1-yn-1-yl, prop-2-yn-1-yl, etc.; butyls such as butan-1-yl, butan-2-yl, 2-methyl-propan-1-yl, 2-methyl-propan-2-yl, cyclobutan-1-yl, but-1-en-1-yl, but-1-en-2-yl, 2-methyl-prop-1-en-1-yl, but-2-en-1-yl, but-2-en-2-yl, buta-1,3-dien-1-yl, buta-1,3-dien-2-yl, cyclobut-1-en-1-yl, cyclobut-1-en-3-yl, cyclobuta-1,3-dien-1-yl, but-1-yn-1-yl, but-1-yn-3-yl, but-3-yn-1-yl, etc.; and the like. Where specific levels of saturation are intended, the nomenclature “alkanyl,” “alkenyl” and/or “alkynyl” is used, as defined below. “Lower alkyl” refers to alkyl groups having from 1 to 6 carbon atoms.
  • “Alkanyl” by itself or as part of another substituent refers to a saturated branched, straight-chain or cyclic alkyl derived by the removal of one hydrogen atom from a single carbon atom of a parent alkane. Typical alkanyl groups include, but are not limited to, methanyl; ethanyl; propanyls such as propan-1-yl, propan-2-yl(isopropyl), cyclopropan-1-yl, etc.; butanyls such as butan-1-yl, butan-2-yl(sec-butyl), 2-methyl-propan-1-yl(isobutyl), 2-methyl-propan-2-yl(t-butyl), cyclobutan-1-yl, etc.; and the like.
  • “Alkenyl” by itself or as part of another substituent refers to an unsaturated branched, straight-chain or cyclic alkyl having at least one carbon-carbon double bond derived by the removal of one hydrogen atom from a single carbon atom of a parent alkene. The group may be in either the cis or trans conformation about the double bond(s). Typical alkenyl groups include, but are not limited to, ethenyl; propenyls such as prop-1-en-1-yl, prop-1-en-2-yl, prop-2-en-1-yl, prop-2-en-2-yl, cycloprop-1-en-1-yl; cycloprop-2-en-1-yl; butenyls such as but-1-en-1-yl, but-1-en-2-yl, 2-methyl-prop-1-en-1-yl, but-2-en-1-yl, but-2-en-2-yl, buta-1,3-dien-1-yl, buta-1,3-dien-2-yl, cyclobut-1-en-1-yl, cyclobut-1-en-3-yl, cyclobuta-1,3-dien-1-yl, etc.; and the like.
  • “Alkyloxyalkyl” refers to a moiety having two alkyl groups tethered together via an oxygen bond. Suitable alkyloxyalkyl groups include polyoxyalkylenes, such as polyethyleneoxides, polypropyleneoxides, etc. that are terminated with an alkyl group, such as a methyl group. A general formula for such compounds can be depicted as R′—(OR″)n or (R′O)nR″ wherein n is an integer from 1 to about 10, and R′ and R″ are alkyl or alkylene groups.
  • “Alkynyl” by itself or as part of another substituent refers to an unsaturated branched, straight-chain or cyclic alkyl having at least one carbon-carbon triple bond derived by the removal of one hydrogen atom from a single carbon atom of a parent alkyne. Typical alkynyl groups include, but are not limited to, ethynyl; propynyls such as prop-1-yn-1-yl, prop-2-yn-1-yl, etc.; butynyls such as but-1-yn-1-yl, but-1-yn-3-yl, but-3-yn-1-yl, etc.; and the like.
  • “Alkyldiyl” by itself or as part of another substituent refers to a saturated or unsaturated, branched, straight-chain or cyclic divalent hydrocarbon group having the stated number of carbon atoms (i.e., C1-C6 means from one to six carbon atoms) derived by the removal of one hydrogen atom from each of two different carbon atoms of a parent alkane, alkene or alkyne, or by the removal of two hydrogen atoms from a single carbon atom of a parent alkane, alkene or alkyne. The two monovalent radical centers or each valency of the divalent radical center can form bonds with the same or different atoms. Typical alkyldiyl groups include, but are not limited to, methandiyl; ethyldiyls such as ethan-1,1-diyl, ethan-1,2-diyl, ethen-1,1-diyl, ethen-1,2-diyl; propyldiyls such as propan-1,1-diyl, propan-1,2-diyl, propan-2,2-diyl, propan-1,3-diyl, cyclopropan-1,1-diyl, cyclopropan-1,2-diyl, prop-1-en-1,1-diyl, prop-1-en-1,2-diyl, prop-2-en-1,2-diyl, prop-1-en-1,3-diyl, cycloprop-1-en-1,2-diyl, cycloprop-2-en-1,2-diyl, cycloprop-2-en-1,1-diyl, prop-1-yn-1,3-diyl, etc.; butyldiyls such as, butan-1,1-diyl, butan-1,2-diyl, butan-1,3-diyl, butan-1,4-diyl, butan-2,2-diyl, 2-methyl-propan-1,1-diyl, 2-methyl-propan-1,2-diyl, cyclobutan-1,1-diyl; cyclobutan-1,2-diyl, cyclobutan-1,3-diyl, but-1-en-1,1-diyl, but-1-en-1,2-diyl, but-1-en-1,3-diyl, but-1-en-1,4-diyl, 2-methyl-prop-1-en-1,1-diyl, 2-methanylidene-propan-1,1-diyl, buta-1,3-dien-1,1-diyl, buta-1,3-dien-1,2-diyl, buta-1,3-dien-1,3-diyl, buta-1,3-dien-1,4-diyl, cyclobut-1-en-1,2-diyl, cyclobut-1-en-1,3-diyl, cyclobut-2-en-1,2-diyl, cyclobuta-1,3-dien-1,2-diyl, cyclobuta-1,3-dien-1,3-diyl, but-1-yn-1,3-diyl, but-1-yn-1,4-diyl, buta-1,3-diyn-1,4-diyl, etc.; and the like. Where specific levels of saturation are intended, the nomenclature alkanyldiyl, alkenyldiyl and/or alkynyldiyl is used. Where it is specifically intended that the two valencies be on the same carbon atom, the nomenclature “alkylidene” is used. A “lower alkyldiyl” is an alkyldiyl group having from 1 to 6 carbon atoms. In some embodiments the alkyldiyl groups are saturated acyclic alkanyldiyl groups in which the radical centers are at the terminal carbons, e.g., methandiyl(methano); ethan-1,2-diyl(ethano); propan-1,3-diyl(propano); butan-1,4-diyl(butano); and the like (also referred to as alkylenes, defined infra).
  • “Alkylene” by itself or as part of another substituent refers to a straight-chain saturated or unsaturated alkyldiyl group having two terminal monovalent radical centers derived by the removal of one hydrogen atom from each of the two terminal carbon atoms of straight-chain parent alkane, alkene or alkyne. The location of a double bond or triple bond, if present, in a particular alkylene is indicated in square brackets. Typical alkylene groups include, but are not limited to, methylene (methano); ethylenes such as ethano, etheno, ethyno; propylenes such as propano, prop[1]eno, propa[1,2]dieno, prop[1]yno, etc.; butylenes such as butano, but[1]eno, but[2]eno, buta[1,3]dieno, but[1]yno, but[2]yno, buta[1,3]diyno, etc.; and the like. Where specific levels of saturation are intended, the nomenclature alkano, alkeno and/or alkyno is used. In some embodiments, the alkylene group is (C1-C6) or (C1-C3) alkylene. Other embodiments include straight-chain saturated alkano groups, e.g., methano, ethano, propano, butano, and the like.
  • “Aryl” by itself or as part of another substituent refers to a monovalent aromatic hydrocarbon group having the stated number of carbon atoms (i.e., C5-C15 means from 5 to 15 carbon atoms) derived by the removal of one hydrogen atom from a single carbon atom of a parent aromatic ring system. Typical aryl groups include, but are not limited to, groups derived from aceanthrylene, acenaphthylene, acephenanthrylene, anthracene, azulene, benzene, chrysene, coronene, fluoranthene, fluorene, hexacene, hexaphene, hexylene, as-indacene, s-indacene, indane, indene, naphthalene, octacene, octaphene, octalene, ovalene, penta-2,4-diene, pentacene, pentalene, pentaphene, perylene, phenalene, phenanthrene, picene, pleiadene, pyrene, pyranthrene, rubicene, triphenylene, trinaphthalene, and the like, as well as the various hydro isomers thereof. In some embodiments, the aryl group is (C5-C15) aryl or, alternatively, (C5-C10) aryl. Other embodiments include phenyl and naphthyl.
  • “Arylakl” by itself or as part of another substituent refers to an acyclic alkyl radical in which one of the hydrogen atoms bonded to a carbon atom, typically a terminal or sp3 carbon atom, is replaced with an aryl group. Typical arylalkyl groups include, but are not limited to, benzyl, 2-phenylethan-1-yl, 2-phenylethen-1-yl, naphthylmethyl, 2-naphthylethan-1-yl, 2-naphthylethen-1-yl, naphthobenzyl, 2-naphthophenylethan-1-yl and the like. Where specific alkyl moieties are intended, the nomenclature arylalkanyl, arylalkenyl and/or arylalkynyl is used. In some embodiments, the arylalkyl group is (C7-C30) arylalkyl, e.g., the alkanyl, alkenyl or alkynyl moiety of the arylalkyl group is (C1-C10) and the aryl moiety is (C5-C20) or, alternatively, an arylalkyl group is (C7-C20) arylalkyl, e.g., the alkanyl, alkenyl or alkynyl moiety of the arylalkyl group is (C1-C8) and the aryl moiety is (C6-C12).
  • “Aryloxyalkyl” refers to a moiety having an aryl group and an alkyl group tethered together via an oxygen bond. Suitable aryloxyalkyl groups include phenyloxyalkylenes, such as methoxyphenyl or ethoxyphenyl.
  • “Cycloalkyl” by itself or as part of another substituent refers to a cyclic version of an “alkyl” group. Typical cycloalkyl groups include, but are not limited to, cyclopropyl; cyclobutyls such as cyclobutanyl and cyclobutenyl; cyclopentyls such as cyclopentanyl and cycloalkenyl; cyclohexyls such as cyclohexanyl and cyclohexenyl; and the like.
  • “Cycloheteroalkyl” by itself or as part of another substituent refers to a saturated or unsaturated cyclic alkyl radical in which one or more carbon atoms (and any associated hydrogen atoms) are independently replaced with the same or different heteroatom. Typical heteroatoms to replace the carbon atom(s) include, but are not limited to, N, P, O, S or Si. Where a specific level of saturation is intended, the nomenclature “cycloheteroalkanyl” or “cycloheteroalkenyl” is used. Typical cycloheteroalkyl groups include, but are not limited to, groups derived from epoxides, imidazolidine, morpholine, piperazine, piperidine, pyrazolidine, pyrrolidine, quinuclidine, and the like.
  • “Halogen” or “Halo” by themselves or as part of another substituent, unless otherwise stated, refer to fluoro, chloro, bromo and iodo.
  • “Haloalkyl” by itself or as part of another substituent refers to an alkyl group in which one or more of the hydrogen atoms are replaced with a halogen. Thus, the term “haloalkyl” is meant to include monohaloalkyls, dihaloalkyls, trihaloalkyls, etc. up to perhaloalkyls. For example, the expression “(C1-C2) haloalkyl” includes fluoromethyl, difluoromethyl, trifluoromethyl, 1-fluoroethyl, 1,1-difluoroethyl, 1,2-difluoroethyl, 1,1,1-trifluoroethyl or perfluoroethyl.
  • “Heteroalkyl, Heteroalkynyl, Heteroalkenyl, Heteroalkynyl” by itself or as part of another substituent refer to alkyl, alkanyl, alkenyl and alkynyl radical, respectively, in which one or more of the carbon atoms (and any associated hydrogen atoms) are each independently replaced with the same or different heteroatomic groups. Typical heteroatomic groups include, but are not limited to, —O—, —S—, —O—O—, —S—S—, —O—S—, —NR′—, ═N—N═, —N═N—, —N═N—NR′—, —PH—, —P(O)2—, —O—P(O)2—, —S(O)—, —S(O)2—, —SnH2— and the like, where R′ is hydrogen, alkyl, substituted alkyl, cycloalkyl, substituted cycloalkyl, aryl or substituted aryl.
  • “Heteroaryl” by itself or as part of another substituent, refers to a monovalent heteroaromatic radical derived by the removal of one hydrogen atom from a single atom of a parent heteroaromatic ring system. Typical heteroaryl groups include, but are not limited to, groups derived from acridine, arsindole, carbazole, β-carboline, benzoxazine, benzimidazole, chromane, chromene, cinnoline, furan, imidazole, indazole, indole, indoline, indolizine, isobenzofuran, isochromene, isoindole, isoindoline, isoquinoline, isothiazole, isoxazole, naphthyridine, oxadiazole, oxazole, perimidine, phenanthridine, phenanthroline, phenazine, phthalazine, pteridine, purine, pyran, pyrazine, pyrazole, pyridazine, pyridine, pyrimidine, pyrrole, pyrrolizine, quinazoline, quinoline, quinolizine, quinoxaline, tetrazole, thiadiazole, thiazole, thiophene, triazole, xanthene, and the like. The heteroaryl group may be from 5-20 membered heteroaryl or, alternatively, from 5-10 membered heteroaryl. In some embodiments, the heteroaryl groups are those derived from thiophene, pyrrole, benzothiophene, benzofuran, indole, pyridine, quinoline, imidazole, oxazole and pyrazine.
  • “Heteroarylalkyl” by itself or as part of another substituent refers to an acyclic alkyl group in which one of the hydrogen atoms bonded to a carbon atom, typically a terminal or sp3 carbon atom, is replaced with a heteroaryl group. Where specific alkyl moieties are intended, the nomenclature heteroarylalkanyl, heteroarylalkenyl and/or heteroarylalkynyl is used. In some embodiments, the heteroarylalkyl group is a 6-21 membered heteroarylalkyl, e.g., the alkanyl, alkenyl or alkynyl moiety of the heteroarylalkyl is (C1-C6) alkyl and the heteroaryl moiety is a 5-15-membered heteroaryl. In other embodiments, the heteroarylalkyl is a 6-13 membered heteroarylalkyl, e.g., the alkanyl, alkenyl or alkynyl moiety is (C1-C3) alkyl and the heteroaryl moiety is a 5-10 membered heteroaryl.
  • “Hydroxyalkyl” by itself or as part of another substituent refers to an alkyl group in which one or more of the hydrogen atoms are replaced with a hydroxyl substituent. Thus, the term “hydroxyalkyl” is meant to include monohydroxyalkyls, dihydroxyalkyls or trihydroxyalkyls.
  • “Parent Aromatic Ring System” refers to an unsaturated cyclic or polycyclic ring system having a conjugated π electron system. Specifically included within the definition of “parent aromatic ring system” are fused ring systems in which one or more of the rings are aromatic and one or more of the rings are saturated or unsaturated, such as, for example, fluorene, indane, indene, phenalene, tetrahydronaphthalene, etc. Typical parent aromatic ring systems include, but are not limited to, aceanthrylene, acenaphthylene, acephenanthrylene, anthracene, azulene, benzene, chrysene, coronene, fluoranthene, fluorene, hexacene, hexaphene, hexylene, indacene, s-indacene, indane, indene, naphthalene, octacene, octaphene, octalene, ovalene, penta-2,4-diene, pentacene, pentalene, pentaphene, perylene, phenalene, phenanthrene, picene, pleiadene, pyrene, pyranthrene, rubicene, tetrahydronaphthalene, triphenylene, trinaphthalene, and the like, as well as the various hydro isomers thereof.
  • “Parent Heteroaromatic Ring System” refers to a parent aromatic ring system in which one or more carbon atoms (and any associated hydrogen atoms) are independently replaced with the same or different heteroatom. Typical heteroatoms to replace the carbon atoms include, but are not limited to, N, P, O, S, Si, etc. Specifically included within the definition of “parent heteroaromatic ring systems” are fused ring systems in which one or more of the rings are aromatic and one or more of the rings are saturated or unsaturated, such as, for example, arsindole, benzodioxan, benzofuran, chromane, chromene, indole, indoline, xanthene, etc. Typical parent heteroaromatic ring systems include, but are not limited to, arsindole, carbazole, β-carboline, chromane, chromene, cinnoline, furan, imidazole, indazole, indole, indoline, indolizine, isobenzofuran, isochromene, isoindole, isoindoline, isoquinoline, isothiazole, isoxazole, naphthyridine, oxadiazole, oxazole, perimidine, phenanthridine, phenanthroline, phenazine, phthalazine, pteridine, purine, pyran, pyrazine, pyrazole, pyridazine, pyridine, pyrimidine, pyrrole, pyrrolizine, quinazoline, quinoline, quinolizine, quinoxaline, tetrazole, thiadiazole, thiazole, thiophene, triazole, xanthene, and the like.
  • “Leaving group” is a group that is displaced during a reaction by a nucleophilic reagent. Suitable leaving groups include S(O)2Me, —SMe or halo (e.g., F, Cl, Br, I).
  • “Linking group” is a group that serves as an intermediate locus between two or more end groups. The nature of the linking group can vary widely, and can include virtually any combination of atoms or groups useful for spacing one molecular moiety from another. For example, the linker may be an acyclic hydrocarbon bridge (e.g., a saturated or unsaturated alkyleno such as methano, ethano, etheno, propano, prop[1]eno, butano, but[1]eno, but[2]eno, buta[1,3]dieno, and the like), a monocyclic or polycyclic hydrocarbon bridge (e.g., [1,2]benzeno, [2,3]naphthaleno, and the like), a simple acyclic heteroatomic or heteroalkyldiyl bridge (e.g., —O—, —S—, —S—O—, —NH—, —PH—, —C(O)—, —C(O)NH—, —S(O)—, —S(O)2—, —S(O)NH—, —S(O)2NH—, —O—CH2—, —CH2—O—CH2—, —O—CH═CH—CH2—, and the like), a monocyclic or polycyclic heteroaryl bridge (e.g., [3,4]furano, pyridino, thiopheno, piperidino, piperazino, pyrazidino, pyrrolidino, and the like) or combinations of such bridges.
  • “Protecting group” is a group that is appended to, for example, a hydroxyl oxygen in place of a labile hydrogen atom. Suitable hydroxyl protecting group(s) include esters (acetate, ethylacetate), ethers (methyl, ethyl), ethoxylated derivatives (ethylene glycol, propylene glycol) and the like that can be removed under either acidic or basic conditions so that the protecting group is removed and replaced with a hydrogen atom. Guidance for selecting appropriate protecting groups, as well as synthetic strategies for their attachment and removal, may be found, for example, in Greene & Wuts, Protective Groups in Organic Synthesis, 3d Edition, John Wiley & Sons, Inc., New York (1999) and the references cited therein (hereinafter “Greene & Wuts”).
  • Plastics or porous membranes such as polyolefins, polystyrenes, poly(methyl)methacrylates, polyacrylonitriles, poly(vinylacetates), poly (vinyl alcohols), chlorine-containing polymers such as poly(vinyl)chloride, polyoxymethylenes, polycarbonates, polyamides, polyimides, polyurethanes, phenolics, amino-epoxy resins, polyesters, silicones, cellulose-based plastics, fluoropolymers and rubber-like plastics can all be used as supports, providing surfaces that can be modified as described herein. In addition, supports such as those formed of pyrolytic carbon, parylene coated surfaces, and silylated surfaces of glass, ceramic, or metal are suitable for surface modification.
  • The method of the present invention may involve the attachment of a biologically active material to a support surface. For example, a thermally responsive nanofiber including a cross-linking agent is provided having two or more latent reactive activatable groups in the presence of a support surface. According to an alternative embodiment, the nanofiber may also include a biologically active material or a functional polymer that is reactive with a biologically active material. At least one of the latent reactive groups is activated and covalently bonded to the surface. The remaining latent reactive groups are allowed to remain in their inactive state and are later activated in order to bind a biologically active material or a functional polymer in order to attach the biologically active material to the surface of the substrate.
  • A functional polymer is a polymer having one or more functional groups that will react with a biologically active material. Representative functional groups include carboxy, ester, epoxy, hydroxyl, amido, amino, thio N-hydroxy succinimide, isocyanate, anhydride, azide, aldehyde, cyanuryl chloride or phosphine groups that will react with a biologically active material
  • Alternatively, the biologically active material or functional polymer provided in the thermally responsive nanofiber composition may bind to a second biological material in order to attach the second biological material to the surface of the substrate through manipulation of the physical properties of the support surface via, for example, the application or removal of heat from the system.
  • The steps of the method can be performed in any suitable order. For example, a thermally responsive nanofiber including a thermally responsive polymer and cross-linking agent, as described herein, may be physically absorbed in or adsorbed to a suitable support surface by hydrophobic interactions. Upon photoactivation, at least one of the photoactivatable groups (e.g., benzophenone groups) undergoes covalent bond formation at the support surface. With the absence of abstractable hydrogens in the proximity of the remaining unbonded photoactivatable group(s), and removal of the photoactivation source, the photoactivatable group returns from an excited state to a ground state. These remaining photoactivatable groups are then capable of being reactivated when a biologically active material intended for immobilization is present, and when the treated surface is exposed to another round of illumination. This method can be described as a “two-step” approach, where the thermally responsive nanofiber is applied in the first step to create a latent reactive surface, and in the second step, the biologically active material is added for attachment to the activated surface.
  • Alternatively, the method, described as a “one-step” method, provides that the thermally responsive nanofibers of the present invention are mixed together with the biologically active material to form a composition. The resultant composition is used to surface modify materials in a single photoactivation step. In this case, photoactivation triggers not only covalent bond formation of at least one photoactivatable group with the surface of the substrate, but also simultaneously triggers covalent bond formation with any adjacent biologically active materials residing on the surface.
  • In an alternative embodiment, the thermally responsive nanofiber is formed from a combination or mixture including a thermally responsive polymer, a cross-linking agent having at least two latent activatable groups, and a biologically active material. At least one of the latent reactive groups undergoes covalent bond formation at the support surface to bond the nanofiber to the surface of the substrate. The remaining latent reactive group(s) can undergo photoactivation to react with a second biologically active material. Alternatively, the biologically active material incorporated into the nanofiber can itself react with a second biologically active material to provide for further functionalization of the substrate.
  • In another alternative method, the thermally responsive nanofibers of the present invention are used to pretreat a substrate surface prior to the application and bonding of molecules that have themselves been functionalized with latent reactive groups. This method is useful in situations where a particularly difficult substrate requires maximal coating durability. In this manner, the number of covalent bonds formed between the substrate surface and the target molecule derivatized with latent reactive groups can typically be increased, as compared to surface modification with a desired latent reactive group-containing target molecule alone.
  • After the surface of a substrate has been coated or treated with the thermally responsive nanofibers of the present invention, the thermally responsive surface can then be fine tuned by the application or removal of heat to the system to selectively bind and release a biological material of interest. Heat can be applied to the system to transition the thermally responsive nanofiber bound to the surface from a hydrophilic state to a hydrophobic state. In a hydrophobic state at a temperature higher than LCST, the polymer chains collapse and the surface becomes hydrophobic. In this state the thermally responsive nanofiber surface may attract or repel select target molecules. Alternatively, heat can also be removed from the system by cooling the substrate below the LCST. Once cooled, the thermally responsive nanofiber may revert back to its initial hydrophilic state, once again showing an altered affinity for a particular target molecule.
  • Suitable biologically active or target molecules for use in the present invention encompass a diverse group of materials or substances. These materials may be used in either an underivatized form or previously derivatized. Moreover, target molecules can be immobilized singly or in combination with other types of target molecules.
  • Target molecules can be immobilized to the surface after (e.g., sequentially) the surface has been primed with the thermally responsive nanofibers of the present invention. Alternatively, target molecules are immobilized during (e.g., simultaneously with) attachment of the thermally responsive nanofibers to the surface of the substrate.
  • Typically, target molecules are selected so as to confer particular desired properties to the surface and/or to the device or article bearing the surface. According to one embodiment of the present invention, the target molecule or material is a biologically active material. Biologically active materials which may be immobilized on the surface of the nanofiber modified substrate, or alternatively, provided as a part of the nanofiber composition, generally include, but are not limited to, the following: enzymes, proteins, carbohydrates, nucleic acids, and mixtures thereof. Further examples of suitable target molecules, including biological materials, and the surface properties they are typically used to provide, is represented by the following nonlimiting list.
  • TARGET MOLECULE FUNCTIONAL ACTIVITY
    Synthetic Polymers
    Sulfonic acid-substituted Lubricity, negatively charged surface,
    polyacrylamide hydrophilicity
    Polyacrylamide Lubricity, protein repulsion, hydrophilicity
    Polyethylene glycol Lubricity, cell and protein repulsion,
    hydrophilicity
    Polyethyleneimine Positively charged surface
    Polylactic acid Bioerodible surface
    Polyvinyl alcohol Lubricity, hydrophilicity
    Polyvinyl pyrrolidone Lubricity, hydrophilicity
    Quaternary amine-substituted Lubricity, positively charged surface
    polyacrylamide
    Silicone Lubricity, hydrophobicity
    Conductive polymeric Electric conductivity
    materials, e.g.,
    polyvinylpyridine,
    polyacetylene, polypyrrole)
    Carbohydrates
    Alginic acid Lubricity, hydrophilicity
    Cellulose Lubricity, hydrophilicity, bio-degradable glucose source
    Chitosan Positively charged surface, hydrophilicity,
    hemostatsis
    Glycogen Hydrophilicity, biodegradable glucose source
    Heparin Antithrombogenicity, hydrophilicity, cell and
    growth factor attachment, protein affinity
    Hyaluronic acid Lubricity, negatively charged surface
    Pectin Lubricity, hydrophilicity
    Mono-, di-saccharides Hydrophilicity
    Dextran sulfate Chromatography media, hydrophilicity
    Proteins
    Antibodies Antigen binding, immunoassay
    Antithrombotic agents (e.g. Antithrombogenic surface
    antithrombin III)
    Albumin Nonthrombogenic surface
    Attachment proteins/peptides Cell attachment
    (e.g. collagen)
    Enzymes Catalytic surface
    Extracellular matrix Cell attachment and growth
    proteins/peptides
    Growth factors, Cell growth
    proteins/peptides
    Hirudin Antithrombogenic surface
    Thrombolytic proteins (e.g., Thrombolytic activity
    streptokinase, plasmin,
    urokinase)
    Lipids
    Fatty acids Hydrophobicity, biocompatibility
    Mono-, di- and triglycerides Hydrophobicity, lubricity, bio-degradable fatty
    acid source
    Phospholipids Hydrophobicity, lubricity, bio-degradable fatty acid source
    Prostaglandins/leukotrienes Nonthrombogenic surface/immobilized
    messenger
    Nucleic Acids
    DNA Substrate for nucleases/affinity binding, genomic
    assay
    RNA Substrate for nucleases/affinity binding, genomic
    assay
    Nucleosides, nucleotides Source of purines, pyrimidines, enzyme cofactor
    Drugs/Vitamins/Cofactors
    Enzyme cofactors Immobilized enzyme
    Heme compounds Globin bindings/surface oxygenation
    Drugs Drug activity
    Nonpolymeric Materials
    Dyes (e.g., azo dyestuffs) Coloring agent
    Fluorescent compounds Fuorescence
    (e.g., fluorescein)
  • The thermally responsive nanofibers of the present invention can be used in a wide variety of applications including: filters, scaffolds for tissue engineering, protective clothing, reinforcement of composite materials, and sensor technologies.
  • Medical articles that can be fabricated from or coated or treated with the thermally responsive nanofibers of the present invention can include, but are not limited to, the following: catheters including urinary catheters and vascular catheters (e.g., peripheral and central vascular catheters), wound drainage tubes, arterial grafts, soft tissue patches, gloves, shunts, stents, tracheal catheters, wound dressings, sutures, guide wires and prosthetic devices (e.g., heart valves and LVADs). Vascular catheters which can be prepared according to the present invention include, but are not limited to, single and multiple lumen central venous catheters, peripherally inserted central venous catheters, emergency infusion catheters, percutaneous sheath introducer systems, thermodilution catheters, including the hubs and ports of such vascular catheters, leads to electronic devices such as pacemakers, defibrillators, artificial hearts, and implanted biosensors.
  • Additional articles that can be fabricated from or have a surface that can be coated or treated with the thermally responsive nanofibers of the present invention can include, but are not limited to, the following: slides, multi-well plates, Petri dishes, tissue culture slides, tissue culture plates, tissue culture flasks, cell culture devices, or column supports and/or chromatography media.
  • In another embodiment, the thermally responsive nanofibers of the present invention can be applied to a microscope slide or “chip” for biomolecule immobilization.
  • In yet another embodiment, the thermally responsive nanofibers of the present invention can be applied to a surface of a cell culture device to provide a thermally responsive surface
  • Various types of mammalian cells have been seeded on tissue culture polystyrene (TCPS) coated with poly-isopropylacrylamide (PIPAAm). The cells adhered, proliferated and differentiated in the same manner as uncoated TCPS. With the cells on bare TCPS, digestive trypsin treatment is carried out to dissolve the extracellular matrix and to chelate and remove Ca ions to release the cells, which in the process lose their cell surface receptors, gap junctions and underlying extracellular matrix. Another alternative for cell release is the use of cell scrapers, the mechanical use of which generates irregularly shaped tissue fragments. With thermo-responsive polymer coated dishes the cells are detached in a non invasive fashion only by reducing the culture temperature from 20°-32° C. at a temperature at which the polymer hydrates. In contrast to enzymatic digestion, both adhesive proteins and cell-cell junctions between the confluent cells are preserved, enabling generation of a three dimensional functional tissue that lacks any scaffold.
  • Cell sheet engineering is a unique technique that has arisen from the use of thermo-responsive polymer as a cell culture substrate. At 37° C., PIPAAm becomes hydrophobic, promoting protein adsorption and thereby cell adhesion. By lowering the temperature to 20°-32° C., cells can be released from the underlying substrate. The change from hydrophobic to hydrophilic character over this transition results in the release of proteins and adherent cells from the culture substrate. Through this technique, cell-cell contacts, gap junctions and surface receptors are maintained as well as the underlying extracellular matrix (ECM). The intact ECM serves as glue to layer cell sheets to form homogenous tissue grafts for example highly pulsatile cardiac tissue grafts or heterogeneous tissue grafts by layering sheets from various different cell types, for example endothelial cells and hepatocytes. The cell sheets thus generated have been highly applicable to animal transplant studies. Transplant experiments have been done to compare the response of dissociated cells versus cell sheet injections. Dissociated cardiomyocytes equivalent to four cell sheets were injected into left subcutaneous dorsal tissue and four cell sheet layers obtained from low temperature lift off mediated by thermo-responsive polymer, were transplanted into the right subcutaneous tissue. The isolated cells formed a lump under the skin while the sheet transplanted site remained smooth. One week after the transplant, the respective sites were opened and cross sectional views of the right side indicated a flat square cardiac graft with no visible necrosis and connexin 43 (a gap junction marker) staining revealed the presence of numerous gap junctions.
  • The left side showed cell dense graft surface zones with central cell-void areas and only a few depositions were seen when stained for connexin 43. The grafting of PIPAAm on tissue culture polystyrene and its success with the culture and harvest of various cell types has led to the development of commercially available tissue culture polystyrene dishes by Cell Seed Inc. (Tokyo, Japan). The use of these surfaces completely abandons the use of trypsin when collecting cells as detachment is achieved by lowering the culture temperature. This eliminates the use of laborious pipetting, saving on both labor, time and cell/tissue damage.
  • The culture surfaces can also be functionalized by co-polymerization of PIPAAm with its carboxylate derivatized analog, 2-carboxyisopropylacrylamide (CIPAAm). Insulin was immobilized on culture surfaces by standard amide bond formation with the CIPAAm carboxylate group. The surfaces with immobilized insulin showed an increase in proliferation of bovine carotid artery endothelial (BAEC) cells even without the addition of serum. Similarly, the carboxyl groups on CIPPAm sequences can be used to immobilize cell adhesive sequences such as RGDS which promotes BAEC cell adhesion and proliferation without the addition of fetal bovine serum in the culture medium. Thus, the culture of cells and their low temperature lift off obviates the need of using serum which has both cost and safety (prions and bovine spongiform encephalopathy) concerns regarding its use. These surfaces would be useful for serum free culture of cells and cell sheets which can then be used in various tissue engineering and transplant applications.
  • The spontaneous cell sheet generation from PIPAAm-grafted TCPS is a relatively slow process, occurring gradually from the sheet periphery toward the interior. Thus, significant incubation time is required to lift up the intact, viable cell sheet completely. Rapid recovery of cell sheets is considered important to maintain biological function and viability of recovered cell sheets, as well as for practical assembly of tissue structures. The rate limiting step to cell recovery is the hydration of hydrophobized PIPAAm segments interacting with the cell sheet, incorporation of a highly water permeable substrate to interface is desirable between cell sheets and the thermo-responsive surfaces. Several approaches have been tried in this regard to make the detachment of cell sheets a faster process. It has been shown that placing hydrophilically-modified PVDF membranes on confluent Madin-Darby canine kidney (MDCK) cells incubated at 20° C. for one hour helps in the easy lift of cells. Another set of experiments has utilized porous membranes (PET) grafted with PIPAAm. As mentioned earlier, on PIPAAm-grafted TCPS dishes, water required to hydrate PIPAAm at a lower temperature can readily penetrate the culture matrix from only the periphery of each cell to the interface between the cell and grafted PIPAAm chains. On porous membranes, water hydration of PIPAAm is supplied through pores underneath adherent cells, as well as from the periphery of each cell. Ready, rapid access of bulk water to PIPAAm grafts through pores beneath attached cells should accelerate single cell and cell sheet detachment. The pore size of a membrane is an important factor in determining the cell adhesion and growth. In general, cells do not grow on surfaces which have a pore size greater than their pseudopodium. On membranes with pore size greater than 5 μm the fibroblast adhesion and suppression was found to be greatly reduced.
  • Nanofibers produced via the process of electrospinning may have unprecedented porosity (>70%), a high surface to volume ratio, and a wide range of pore diameter distribution and high interconnectivity, all physical properties ideal for promoting cell attachment and growth. Furthermore, the nanotopography of electrospun nanofibers closely resembles the nanofibrillar and nanoporous 3D geometry of the ECM and basement membrane. The higher surface area allows for a higher percentage of cellular attachment as well as for multiple focal adhesion points on different fibers due to nano-sized fiber diameters. Because the diameters of nanofibers are orders of magnitude smaller than the size of the cells, cells are able to organize, spread or attach to adsorbed proteins at multiple focal points.
  • Electrospun nanofibers are capable of supporting a wide variety of cell types. Human umbilical cord endothelial cells attached and proliferated better when seeded onto 50:50 poly (L-lactic acid-co-ε-caprolactone) (PLCL) fibers with a diameter of 300 nm compared to 7 μm microfibers. Cells attached to microfibers were round in shape and non-proliferative, whereas on nanofibers, the cells were nicely spread out and anchored on multiple fibers. Elias and co-workers have reported osteoblast adhesion, proliferation, alkaline phosphatase activity and ECM secretion on carbon nanofibers increased with decreasing fiber diameter in the range of 60-200 nm. Nanogrooved surfaces can induce contact guidance of human corneal epithelial cells, causing them to elongate and align their cytoskeleton along the topological features. Highly porous PLLA scaffolds with nanoscale pores created using a liquid-liquid phase separation have been used for the culture of neural stem cells and were shown to have a positive effect on neurite outgrowth. Recent studies show that the growth of NIH 3T3 fibroblasts and normal rat kidney cells on polyamide nanofibrillar surfaces resulted in changes in morphology, actin organization, focal adhesion assembly, fibronectin secretion and rates of cell proliferation that are more representative of fibroblast phenotype in vivo. Breast epithelial cells on the same surface underwent morphogenesis to form multicellular spheroids unlike the same cells cultured on glass. It has also been shown that the commercially available polyamide nanofibers provide a better substrate for cell attachment for weakly adherent cell lines, for example PC12, a neuronal cell line. Polyamide electrospun nanofibers have also been shown to support the attachment and proliferation of mouse embryonic stem cells (ES-D3). These cells differentiated into neurons, oligodendrocytes and astrocytes based upon the culture media selected. Fetal bovine chondrocytes seeded on nanofibers poly (ε-caprolactone) (PCL) scaffolds were able to maintain the chondrocytic phenotype during three weeks of culture, specifically upregulating collagen type JIB expression, indicative of mature chondrocyte phenotype. These studies demonstrate that nanofiber scaffolds are not only cytocompatible but can also be used to stimulate and encourage cell proliferation and phenotypic behavior.
  • To induce specific biological responses from the attached cells, the nanofibers may also be functionalized using bioactive molecules. Functionalization is typically carried out by either conjugating the molecules to the surface of the nanofibers or by incorporating the bioactive molecules in the spinning solution. Polyacrylic acid (PAA) grafted onto poly (ε-caprolactone-coethyl ethylene phosphate) (PCLEEP) allows for the conjugation of galactose ligand, which mediates hepatocytes attachment. Hepatocytes cultured on these PCLEEP functionalized nanofiber scaffolds formed 20-100 μm spheroid aggregates that engulfed the nanofibers. To underscore the importance of culture substrate, others have shown that aminated nanofiber meshes supported a higher degree of cell adhesion and proliferation of hematopoietic stem/progenitor cells compared to aminated films. Similarly conjugation of bone morphogenetic protein-2 (BMP-2) on chitosan nanofibers resulted in better proliferation, alkaline phosphatase activity and calcium deposition of osteoblastic cells.
  • In sum, the nanoscale nature of the electrospun polymeric nanofibers mimics the natural ECM. ECM-like properties of the nanofibers can be used to stimulate and encourage cell proliferation and differentiation. Moreover, the cells are able to maintain their in vivo like morphology and function. Thus, the combination of fiber composition, morphology, alignment and the capacity to incorporate bioactive molecules or growth factors helps recreate the functions of native ECM.
  • The invention will be further described with reference to the following non-limiting examples. It will be apparent to those skilled in the art that many changes can be made in the embodiments described without departing from the scope of the present invention. Thus the scope of the present invention should not be limited to the embodiments described in this application, but only by embodiments described by the language of the claims and the equivalents of those embodiments. Unless otherwise indicated, all percentages are by weight.
  • EXAMPLES Example 1 Electrospinning of PCL and PS Nanofibers
  • Poly (ε-caprolactone) (PCL), with an average molecular weight of 80 kDa and Polystyrene (350,000 Da) were purchased from Aldrich chemicals (Milwaukee, Wis.). 0.14 g/ml solutions were prepared by dissolving 14 g of PCL or PS in 100 ml of organic solvent mixture (1:1) composed of tetrahydrofuran (Fisher Scientific) and N,N-dimethylformamide (Alfa Aesar, Ward Hill, Mass.) and mixing it well by shaking the mixture for 24 h at room temperature. The polymer solution was placed in a plastic syringe fitted with a 27G blunt needle (Strategic Applications, Inc., Libertyville, Ill.). A syringe pump (KD Scientific, USA) was used to feed the polymer solution into the needle tip. Nanofiber meshes were fabricated by electrospinning using a high voltage power supply (Gamma High Voltage Research, USA). The nanofibers were collected onto grounded aluminum foil located at a fixed distance from the needle tip. The meshes were then removed, placed in a vacuum chamber for at least 48 h to remove organic solvent residue and then stored in a dessicator. The nanofibers were evaluated with a microscope (Olympus BX 60).
  • Parameters that significantly influence the diameter, consistency and uniformity of the electrospun PCL and PS fibers were polymer concentration, applied voltage, solution feeding rate and needle-collector distance. These parameters were optimized until unbeaded and uniform fibers were spun continuously without needle clogging. Three polymer concentrations (0.10 g/ml, 0.12 g/ml, and 0.14 g/ml), two voltages (17 kv, 20 kv) and three needle-collector distances (8 cm, 12 cm, 15 cm) were investigated to obtain non-defect nanofibers. The optimized conditions are shown in Table 1.
  • TABLE 1
    Electrospinning Parameters
    Polymer concentration 0.14 g/ml
    Applied voltage
      20 kv
    Flow rate 0.02 ml/min
    Needle-collector distance   12 cm
  • FIG. 1. shows the typical SEM image of PCL nanofibers. The average fiber diameter of nanofibers is, 453±146 nm. Highly porous structure was observed in the formulation tested. The porosity measured by a liquid displacement method was 0.90
  • Example 2 Coating of Nanofiber Meshes with (PIPAAm)
  • Various coating approaches were employed to obtain a thin coating of the thermo-responsive polymer on different culture substrates. The substrates included TCPS, Thermanox coverslips (Nunc), commercially available nanofiber meshes (Surmodics Inc., Corning Inc.) and in-house PCL nanofibers. The Thermanox coverslips and nanofiber inserts were dip coated in an IPA (isopropyl alcohol) solution of 20 mg/ml PIPAAm (polyisopropylacrylamide Aldrich chemicals, Mw+20-25 KDa, WI) and 0.8 mg/ml TriLite (tris[2-hydroxy-3-(4-benzoylphenoxy)propl]isocyanurate. The pieces were dip coated by immersing in the coating solution for 10 seconds and then extracted at a speed of 0.5 cm/sec. The meshes were air dried and then UV illuminated (300-400 nm, Harland Medical UVM400, MN) for 5 minutes. Various dipping speeds, concentrations, number of dips and immerse times were tried. The efficacy of the coated surfaces was tested by the attachment and detachment behavior of the BAEC cells (Lonza Biosciences, NJ, USA) at 37° C. and 20° C. respectively. Although the above mentioned conditions worked well for cell attachment and detachment, this dipping method could not coat the tissue culture formatted surfaces (for example, multi well dishes or 100 mm dishes). Therefore, another approach was tried where the multi well dishes, nanofiber inserts, commercially available nanofiber 96 well and 100 mm dishes were first coated with 0.8 mg/ml solution of TriLite. The TriLite solution was immediately withdrawn and UV illuminated for 30 seconds. PIPAAm solution (20 mg/ml in IPA) was then added to the wells, immediately withdrawn and UV illuminated for 2.0 minutes. The treated surfaces were rinsed with IPA and tissue culture grade sterile water before plating the cells.
  • Example 3 Smart Polymer Nanofibers
  • Four formulations containing 1.0 wt % TriLite were prepared to synthesize smart polymer photoreactive nanofibers. These formulations were PS in (DMF/THF), PCL in (DMF/THF), PIPAAm in (IPA/DMF), PIPAAm-co-PEG (1%) in water. The nanofibers were fabricated by the electrospinning process of Example 2. The parameters such as, polymer concentration, solvent ratio, applied voltage and needle-collector distance, were optimized until unbeaded and uniform fibers with an average diameter under 500 nm can be spun continuously without needle clogging. The optimized conditions are shown in Table 2. After drying, all the nanofibers except PS and PCL were illuminated for 5 minutes under a UV lamp (Harland Medical UVM400, Eden Prairie, Minn.). The nanofibers were evaluated under a microscope. PEG-PIPAAm was synthesized by free radical copolymerization of N-isopropylacrylamide (Aldrich) with poly (ethyleneglycol) methyl ether methacrylate (Mw 2,000, Aldrich) in water using ammonium persulfate (Sigma) as initiator and N,N,N′,N′-tetramethylethylenediamine (Aldrich) as a catalyst.
  • TABLE 2
    Feeding Needle-
    Polymer Applied Rate Collector
    Polymer Solvent Concentration Voltage ml/min Distance
    PS THF/DMF 14% 20 kv .02 12 cm
    PCL THF/DMF 14% 20 kv .02 12 cm
    PIPAAm IPA/DMF 25% 16 kv 0.1  6 cm
    PEG- water 5% 16 kv 0.2  6 cm
    PIPAAm
  • Example 4 Surface Characterization and Screening of PIPAAm Coated Nanofibers
  • As the coated nanofiber meshes were completed they were examined for surface topography, protein adsorption, and contact angle. Initially they were screened in house for uniformity by microscopic examination (looking for changes in pore size, and obvious delamination or uncoated areas) and for contact angles. Comparison between bulk PIPAAm, the coated and uncoated nanofiber mesh, and the hydrophobic polystyrene core will provide evidence for surface changes. Microscopic examination of the coated nanofibers showed no obvious delamination or changes in the morphology compared to the uncoated nanofibers.
  • Coatings which passed initial screening were assessed for protein adsorption. PIPAAm surfaces at 37° C. should adsorb considerably more protein than at 25° C. because of the phase transition. Coated and uncoated TCPS coverslips, incubated in 1×PBS buffer at 37° C. and 4° C. for two hours, then quickly removed and placed in a solution of 1 mg/ml BSA for 6 hours at 37° C. and 4° C. This time period should be enough for protein adsorption to occur. Following the BSA incubation, the pieces were rinsed three times with 1×PBS and placed in HRP-labeled anti-BSA antibody (Sigma) for 30 minutes, followed by a standard rinse and HRP colorimetric assay. Pieces were considered coated with the thermo-responsive polymer if the difference in protein adsorption between 37° C. and 25° C. incubated coated pieces exceeds one standard deviation and differs significantly from that of uncoated pieces.
  • Alternatively, we also adsorbed a cell adhesive protein, Fibronectin (FN). Bovine plasma FN (Biomedical Technology Inc, MA) was adsorbed onto the nanofibrillar surfaces by incubation of 10 μg/ml FN in PBS solution at 37° C. and 25° C. for 6 hours. The coated pieces were then vigorously washed with PBS for five times. They were blocked with 0.1% bovine serum albumin (BSA) in PBS for one hour and reacted with 2.0 mg/ml rabbit polyclonal anti bovine FN antibody (Biogenesis, Inc, UK) at a 1:200 dilution (final concentration, 10 μg/ml) for 2 hours at 37° C. and 25° C. respectively. Following five washes with PBS, containing 0.1% BSA, they were incubated for an additional one hour with anti rabbit IgG-HRP antibody (Chemicon International, CA) with a 1:1000 dilution (final concentration 15 ug/ml) and incubated with HRP substrate for 10 minutes. The color development was quenched with I.0N H2S04 and absorbance measurements were taken at 450 nm with a spectrophotometer (Spectramax M2).
  • A ten fold difference in protein adsorption was seen on PIPAAm coated surfaces incubated at 37° C. and 25° C. respectively. Surfaces that showed a difference in protein adsorption at 37° C. and 25° C. were further evaluated for their cell attachment and detachment profile by plating different cell lines.
  • Example 5 Cultured Bovine and Human Cells
  • Bovine Aortic Endothelial Cells (BAEC) and T47-D cells were pre-cultured in 75 cm2 flasks in DMEM-F12+10% FBS. The cells were trypsinized and plated on PIPAAm coated nanofibrillar and TCPS surfaces. The cells were also plated on commercially available PIPAAm coated TCPS surfaces (Cell Seed Inc). Both cell lines were plated at a density of 100,000 cells/well in a 6-well PIPAAm coated dishes. Bare TCPS and Cell Seed surfaces were used as control surfaces and similar numbers of cells were plated on them. The cells were cultured for a period of 48 hours in a humidified atmosphere with 5% C02 at 37° C. Both the cell lines attached well to the coated surfaces which indicate that the coating is thin enough for the cells to attach. Forty eight hours later, the cells were moved to room temperature. The BAEC cells plated on PIPAAm coated nanofibers, TCPS and Cell seed surfaces started to lift up in about 15-20 minutes. Approximately, after about 35 minutes complete cell sheets lifted up (FIG. 4). The results were more dramatic with T47-D cells. After 25 minutes incubation at room temperature, the cells begun to sheet off from the PIPAAm/TriLite coated nanofibrillar and TCPS surfaces while the cells plated on Cell Seed surfaces failed to lift up even after 120 minutes of incubation at room temperature. It was observed that on Cell Seed surfaces, there was no cell detachment while 50-70% of the cells lifted up from PIPAAm/TriLite coated surfaces in about half the time (FIG. 5).
  • Example 6 Cultured Human Epithelial Cells
  • It has been shown that cells growing on nanofibrillar surfaces form more in vivo like morphologies. These surfaces are also permissive for epithelial cells to undergo morphogenesis. We have shown that our coating on smart polymer surfaces does not interfere with the nanofibrillar properties of the matrix and cells still undergo morphogenesis or form more in vivo like structures in addition to being detached by mere temperature reduction.
  • For morphogenesis studies, T47-D breast epithelial cells were cultured on nanofibrillar and flat surfaces coated with PIPAAm/TriLite. The controls were bare nanofibers and TCPS. The cells were cultured in DMEM+10% fetal bovine serum (FBS) in an atmosphere of 5% CO2, 95% air at 37° C. This particular cell line has been selected as it has shown to demonstrate tubular and spheroidal structures under conditions that promote three dimensional interactions with collagen or matrigel. After, 10 days in culture, cells were fixed with 4% paraformaldehyde and incubated with Phalloidin Alexa Fluor 594 (1:500, Molecular Probes, OR) for 30 minutes at room temperature. The cells were rinsed three times with PBS and observed under an inverted fluorescent microscope (Zeiss Axiovert 200M). Phalloidin binds to filamentous actin (F-actin) and provides visualization of cytoskeletal organization of the cells. After 5 days in culture, a mixed population of spheroids and tubular cells was observed on nanofibers. By day 8, multicellular spheroids were dominant although some tubules still persisted. In contrast, the growth of T47-D cells on flat surfaces showed a monolayer with a group of stress fibers. We have shown that our coating on the nanofiber surface with the thermo-responsive polymer does not affect the nanofibrillar topology and hence morphogenesis of T47-D cells or more in vivo like cells can be obtained on these surfaces by mere reduction of temperature. To show that detached cells recover quickly on fresh surfaces and still retain their morphology after temperature reduction, the second set of cells was grown to confluency for about 5-10 days at 37° C. The cells were then moved to room temperature for about 15-40 minutes. The detached cell sheet was gently removed with the help of a 10.0 ml pipette to a fresh tissue culture surface. The cells were allowed to settle down and were then fixed with 4% paraformaldehyde after 30 minutes incubation at 37° C. Replated cells were stained with phalloidin F-actin to show that the advantage of growing cells on thermo-responsive nanofibrillar surfaces as opposed to flat thermo-responsive surfaces is the ability to achieve and retain in vivo like morphology (D).
  • FIG. 7A shows the T47-D cells cultured on PIPAAm/TriLite coated nanofibers for a period of 10 days and stained with Phalloidin F-actin. Note the presence of multicellular spheroids and the peripheral organization of actin filaments. A magnified image (400 μm) of the spheroid of FIG. 7B shows the lumen extending through the spheroid. T47-D cells cultured on PIPAAm/TriLite coated TCPS for period of 10 days were also fixed and stained for phalloidin F-actin. Note the spread out morphology and organization of stress fibers in the cells of FIG. 7C. T47-D cells lifted up through temperature reduction were replated on fresh nanofibers. FIG. 7D shows that replated T47-D cells maintain their tubular and spheroidal morphology and peripheral organization of actin (200 μm).
  • Replated cell sheets were also analyzed for conexxin 43 expression which is considered to be a major component of gap junctional channel. BAEC cells were plated at a density of 50,000 cells/22 mm well. The cells were cultured until confluency and then lifted up by moving the dish to 20° C. for 15 minutes. The sheets were transferred onto fresh nanofibrillar surfaces with the help of a 10 ml pipette and the curled up edges were uncurled by adding a drop of medium onto the sheet. The sheet was then transferred to the 5% CO2 humidified incubator at 37° C. and were allowed to attach. Thirty minutes later the cells were fixed with 4% paraformaldehyde and stained with 1:1000 dilution of anti connexin 43 (Sigma). Staining for Connexin 43 showed diffused expression of connexin 43 through out the entire sheet suggesting the presence of intact gap junctions (FIG. 8).

Claims (33)

1.-17. (canceled)
18. A cell culture article comprising a surface and a thermally responsive polymer, wherein the thermally responsive polymer is associated with the surface via a crosslinking agent having at least two latent reactive groups.
19. The article according to claim 18 wherein the thermally responsive polymer comprises a polymer which has a first physical property at a first predetermined temperature range and a second physical property at a second predetermined temperature range.
20. The article according to claim 18 wherein at least one of the latent reactive groups comprises a photochemical reactive group.
21. The article according to claim 20 wherein the photochemical reactive group is an aryl ketone.
22. The article according to claim 21 wherein the aryl ketone is selected from the group acetophenone, benzophenone, anthraquinone, anthrone, acridone, xanthone, and thioxanthone.
23. The article according to claim 20 wherein all of the latent reactive groups of the crosslinking agent are photochemical reactive groups.
24. The article according to claim 23 wherein all of the photochemical reactive groups are the same.
25. The article according to claim 18 wherein at least one of the latent reactive groups is an aryl azide.
26. The article according to claim 18 wherein at least one of the latent reactive groups comprises a thermally-reactive group.
27. The article according to claim 23 wherein the thermally-reactive group includes a heat labile bond selected from oxygen-oxygen bonds, nitrogen-oxygen bonds, and nitrogen-nitrogen bonds.
28. The article according to claim 26 wherein all of the latent reactive groups of the crosslinking agent comprise thermally-reactive groups.
29. The article according to claim 28 wherein all of the thermally-reactive groups are the same.
30. The article according to claim 18 wherein the crosslinking agent is a monomeric material.
31. The article according to claim 18 wherein the crosslinking agent is a compound having a formulae selected from (a)-(g):

L-(D-T-C(R1)(XP)CHR2GR3C(═O)R4)m  (a)
wherein L is a linking group;
D is CR6R7;
T is (—CH2—)x, (—CH2CH2—O—)x, (—CH2CH2CH2—O—)x, (—CH2CH2CH2CH2—O—)x or forms a bond;
R1 is a hydrogen atom, an alkyl, alkyloxyalkyl, aryl, aryloxyalkyl or aryloxyaryl group;
X is O, S, or NR8R9;
P is a hydrogen atom or a protecting group, with the proviso that P is absent when X is NR8R9;
R2 is a hydrogen atom, an alkyl, alkyloxyalkyl, aryl, aryloxyalkyl or aryloxyaryl group;
G is O, S, SO, SO2, NR10, (CH2)t—O— or C═O;
R3 and R4 are each independently an alkyl, aryl, arylalkyl, heteroaryl, or an heteroarylalkyl group or optionally, R3 and R4 can be tethered together via (—CH2—)q, (—CH2—)rC═O(—CH2—)s, (—CH2—)rS(—CH2—)x, (—CH2—)rS═O(—CH2—)s or (—CH2—)rS(O)2(—CH2—)s, (—CH2—)rNR(—CH2—)s;
R10 is a hydrogen atom or an alkyl, aryl or arylalkyl group;
R6 and R7 are each independently a hydrogen atom, an alkyl, aryl, arylalkyl, heteroaryl or heteroarylalkyl group;
R8 and R9 are each independently a hydrogen atom, an alkyl, aryl, or arylalkyl group;
R is a hydrogen atom, an alkyl or an aryl group;
q is an integer from 1 to about 7;
r is an integer from 0 to about 3;
s is an integer from 0 to about 3;
m is an integer from 2 to about 10;
t is an integer from 1 to about 10; and
x is an integer from 1 to about 500;

L-(T-C(R1)(XP)CHR2GR3C(═O)R4)m  (b)
wherein L is a linking group;
T is (—CH2—)x, (—CH2CH2—O—)x, (—CH2CH2CH2—O—)x, (—CH2CH2CH2CH2—O—)x or forms a bond;
R1 is a hydrogen atom, an alkyl, alkyloxyalkyl, aryl, aryloxyalkyl or aryloxyaryl group;
X is O, S, or NR8R9;
P is a hydrogen atom or a protecting group, with the proviso that P is absent when X is NR8R9;
R2 is a hydrogen atom, an alkyl, alkyloxyalkyl, aryl, aryloxyalkyl or aryloxyaryl group;
G is O, S, SO, SO2, NR10, (CH2)t—O— or C═O;
R3 and R4 are each independently an alkyl, aryl, arylalkyl, heteroaryl, or an heteroarylalkyl group, or optionally, R3 and R4 can be tethered together via (—CH2—)q, (—CH2—)rC═O(—CH2—)s, (—CH2—)rS(—CH2—)s, (—CH2—)rS═O(—CH2—)s or (—CH2—)rS(O)2(—CH2—)s, (—CH2—)r—NR(—CH2—)s;
R10 is a hydrogen atom or an alkyl, aryl or arylalkyl group;
R8 and R9 are each independently a hydrogen atom, an alkyl, aryl, or arylalkyl group;
R is a hydrogen atom, an alkyl or aryl group;
q is an integer from 1 to about 7;
r is an integer from 0 to about 3;
s is an integer from 0 to about 3;
m is an integer from 2 to about 10;
t is an integer from 1 to about 10; and
x is an integer from 1 to about 500;

L-(GTZR3C(═O)R4)m  (c)
wherein L is a linking group;
T is (—CH2—)x, (—CH2CH2—O—)x, (—CH2CH2CH2—O—)x, (—CH2CH2CH2CH2—O—)x or forms a bond;
G is O, S, SO, SO2, NR10, (CH2)t—O— or C═O;
Z is C═O, COO, or CONH when T is (—CH2—)x;
R3 and R4 are each independently an alkyl, aryl, arylalkyl, heteroaryl, or an heteroarylalkyl group, or optionally, R3 and R4 can be tethered together via (—CH2—)q, (—CH2—)rC═O(—CH2—)s, (—CH2—)rS(—CH2—)s, (—CH2—)rS═O(—CH2—)s or (—CH2—)rS(O)2(—CH2—)s, (—CH2—)rNR(—CH2—)s;
R is a hydrogen atom or an alkyl or aryl group;
q is an integer from 1 to about 7;
r is an integer from 0 to about 3;
s is an integer from 0 to about 3;
m is an integer from 2 to about 10;
t is an integer from 1 to about 10; and
x is an integer from 1 to about 500;

L-(TGQR3C(═O)R4)m  (d)
wherein L is a linking group;
T is (—CH2—)x, (—CH2CH2—O—)x, (—CH2CH2CH2—O—)x, (—CH2CH2CH2CH2—O—)x or forms a bond;
G is O, S, SO, SO2, NR10, (CH2)t—O— or C═O;
Q is (—CH2—)p, (—CH2CH2—O—)p, (—CH2CH2CH2—O—)p or (—CH2CH2CH2CH2—O—)p;
R3 and R4 are each independently an alkyl, aryl, arylalkyl, heteroaryl, or an heteroarylalkyl group, or optionally, R3 and R4 can be tethered together via (—CH2—)q, (—CH2—)rC═O(—CH2—)s, (—CH2—)rS(—CH2—)s, (—CH2—)rS═O(—CH2—)s or (—CH2—)rS(O)2(—CH2—)s, (—CH2—)rNR(—CH2—)s;
R10 is a hydrogen atom or an alkyl, aryl, or an arylalkyl group;
R is a hydrogen atom or an alkyl or aryl group;
q is an integer from 1 to about 7;
r is an integer from 0 to about 3;
s is an integer from 0 to about 3;
m is an integer from 2 to about 10;
p is an integer from 1 to about 10;
t is an integer from 1 to about 10; and
x is an integer from 1 to about 500;

L-(—CH2—)xxC(R1)(GR3C(═O)R4)m  (e)
wherein L is a linking group;
R1 is a hydrogen atom, an alkyl, alkyloxyalkyl, aryl, aryloxyalkyl, or aryloxyaryl group;
each G is G is O, S, SO, SO2, NR10, (CH2)t—O— or C═O;
each R3 and R4 is independently an alkyl, aryl, arylalkyl, heteroaryl, or an heteroarylalkyl group, or optionally, R3 and R4 can be tethered together via (—CH2—)q, (—CH2—)rC═O(—CH2—)s, (—CH2—)rS(—CH2—)s, (—CH2—)rS═O(—CH2—)s or (—CH2—)rS(O)2(—CH2—)s, (—CH2—)rNR(—CH2—)s;
each R10 is a hydrogen atom or an alkyl, aryl, or an arylalkyl group;
each R is a hydrogen atom or an alkyl or aryl group;
each q is an integer from 1 to about 7;
each r is an integer from 0 to about 3;
each s is an integer from 0 to about 3;
m is an integer from 2 to about 10;
each t is an integer from 1 to about 10; and
xx is an integer from 1 to about 10;

L-(-C(R1)(XP)CHR2GR3C(═O)R4)m  (f)
wherein L is a linking group;
R1 is a hydrogen atom, an alkyl, alkyloxyalkyl, aryl, aryloxyalkyl or aryloxyaryl group;
X is O, S, or NR8R9;
P is a hydrogen atom or a protecting group, with the 27. that P is absent when X is NR8R9;
R2 is a hydrogen atom, an alkyl, alkyloxyalkyl, aryl, aryloxyalkyl or aryloxyaryl group;
G is G is O, S, SO, SO2, NR10, (CH2)t—O— or C═O;
R3 and R4 are each independently an alkyl, aryl, arylalkyl, heteroaryl, or an heteroarylalkyl group, or optionally, R3 and R4 can be tethered together via (—CH2—)q, (—CH2—)rC═O(—CH2—)s, (—CH2—)rS(—CH2—)s, (—CH2—)rS═O(—CH2—)s or (—CH2—)rS(O)2(—CH2—)s, (—CH2—)rNR(—CH2—)s;
R8 and R9 are each independently a hydrogen atom, an alkyl, aryl, or arylalkyl group;
R10 is a hydrogen atom or an alkyl, aryl, or an arylalkyl group;
R is a hydrogen atom, an alkyl or an aryl group;
q is an integer from 1 to about 7;
r is an integer from 0 to about 3;
s is an integer from 0 to about 3;
m is an integer from 2 to about 10; and
t is an integer from 1 to about 10; and

L-(GR3C(═O)R4)m;  (g)
wherein L is a linking group;
G is O, S, SO, SO2, NR10, (CH2)t—O— or C═O;
R3 and R4 are each independently an alkyl, aryl, arylalkyl, heteroaryl, or an heteroarylalkyl group, or optionally, R3 and R4 can be tethered together via (—CH2—)q, (—CH2—)rC═O(—CH2—)s, (—CH2—)rS(—CH2—)s, (—CH2—)rS═O(—CH2—)s or (—CH2—)rS(O)2(—CH2—)s, (—CH2—)rNR(—CH2—)s;
R is a hydrogen atom, an alkyl or an aryl group;
q is an integer from 1 to about 7;
r is an integer from 0 to about 3;
s is an integer from 0 to about 3;
m is an integer from 2 to about 10; and
t is an integer from 1 to about 10.
32. The article according to claim 31 wherein the crosslinking agent is a compound of formula:
Figure US20100255581A1-20101007-C00010
33. The article according to claim 18 wherein the cell culture article comprises a nanofiber or nanofiber mesh.
34. The article according to claim 18 wherein the cell culture article is selected from slides, multi-well plates, Petri dishes, tissue culture plates, tissue culture flasks, and coverslips.
35. The article according to claim 33 wherein the nanofiber or nanofiber mesh is provided on a surface of a slide, multi-well plate, Petri dish, tissue culture plate, tissue culture flask or coverslip.
36. The article according to claim 18 wherein the surface comprises a polyolefin, polystyrene, poly(methyl)methacrylate, polyacrylonitrile, poly(vinylacetate), poly(vinyl alcohol), chlorine-containing polymer, polyoxymethylene, polycarbonate, polyamide, polyimide, polyurethane, phenolic, amino-epoxy resin, polyester, silicone, cellulose-based plastic, fluoropolymer or rubber-like plastics.
37. The article according to claim 18 wherein the surface comprises pyrolytic carbon, parylene coated surface, or a silylated surface of glass, ceramic or metal.
38. The article according to claim 18 wherein the thermally responsive polymer comprises poly(isopropylacrylamide), copolymers of polyethylene glycol and poly(isopropylacrylamide), or mixtures thereof.
39. A cell culture article comprising a surface and a stimuli responsive polymer which undergoes a physical or chemical change when exposed to external stimuli, wherein the stimuli responsive polymer is associated with the surface via a crosslinking agent having at least two latent reactive groups.
40. A kit for preparing a cell culture article, the kit comprising: a stimuli responsive polymer suitable for cell culture, which polymer undergoes a physical or chemical change when exposed to external stimuli; and a crosslinking agent having at least two latent reactive groups, the crosslinking agent being adapted for associating the stimuli responsive polymer to a surface of a cell culture article.
41. A method for preparing a cell culture article, the method comprising steps of:
(a) contacting a surface of the cell culture article with a coating composition, the coating composition comprising a stimuli responsive polymer which undergoes a physical or chemical change when exposed to external stimuli, and a crosslinking agent having at least two latent reactive groups; and
(b) treating the coating composition to activate latent reactive groups of the crosslinking agent, thereby coupling the stimuli responsive polymer to the surface of the cell culture article in a manner in which at least some of the latent reactive groups remain in an inactive state.
42. The method according to claim 41 further comprising a step of coupling a biologically active material to the surface of the cell culture device by activating remaining latent reactive groups of step (b).
43. A method for preparing a cell culture article, the method comprising steps of:
(a) contacting a surface of the cell culture article with a coating composition comprising a stimuli responsive polymer which undergoes a physical or chemical change when exposed to external stimuli, a crosslinking agent having at least two latent reactive groups, and a biologically active material; and
(b) treating the coating composition to activate latent reactive groups of the crosslinking agent to form a coating on the cell culture device surface.
44. A method for preparing a cell culture article, the method comprising steps of:
(a) contacting a surface of the cell culture article with a crosslinking agent having at least two latent reactive groups;
(b) treating the crosslinking agent to activate less than all of the latent reactive groups of the crosslinking agent, thereby coupling the crosslinking agent to the surface of the cell culture and allowing at least some of the latent reactive groups to remain in an inactive state;
(c) contacting the surface of the cell culture article with a stimuli responsive polymer which undergoes a physical or chemical change when exposed to external stimuli;
(d) treating the surface of the cell culture article to activate latent reactive groups which are present in an inactive state subsequent to step (b), thereby coupling the stimuli responsive polymer to the cell culture article surface.
45. A method for preparing a cell culture article, the method comprising steps of:
(a) preparing a composition comprising a stimuli responsive polymer which undergoes a physical or chemical change when exposed to external stimuli, and a crosslinking agent having at least two latent reactive groups;
(b) forming a cell culture article from the composition of step (a); and
(c) treating the cell culture article formed in step (b) to activate latent reactive groups of the crosslinking agent.
46. The method according to claim 45, wherein the step of forming a cell culture article comprises forming a nanofiber.
47. A method for preparing a cell culture article, the method comprising steps of:
(a) preparing a composition comprising a polymer and a crosslinking agent having at least two latent reactive groups;
(b) forming a cell culture article from the composition of step (a);
(c) contacting a surface of the cell culture article with a stimuli responsive polymer which undergoes a physical or chemical change when exposed to external stimuli; and
(d) treating the surface of the cell culture article to activate latent reactive groups of the crosslinking agent, thereby coupling the stimuli responsive polymer to the cell culture article surface.
48. The method according to claim 47 wherein the polymer of step (a) comprises a polyolefin, polystyrene, poly(methyl)methacrylate, polyacrylonitrile, poly(vinylacetate), poly(vinyl alcohol), chlorine-containing polymer, polyoxymethylene, polycarbonate, polyamide, polyimide, polyurethane, phenolic, amino-epoxy resin, polyester, silicone, cellulose-based plastic, fluoropolymer or rubber-like plastic.
49. The article according to claim 47 wherein the polymer of step (a) comprises pyrolytic carbon, or a silylated surface of glass, ceramic or metal.
US12/666,168 2007-06-22 2008-06-20 Stimuli responsive nanofibers Abandoned US20100255581A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US12/666,168 US20100255581A1 (en) 2007-06-22 2008-06-20 Stimuli responsive nanofibers

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US94580107P 2007-06-22 2007-06-22
PCT/US2008/067708 WO2009002858A2 (en) 2007-06-22 2008-06-20 Stimuli responsive nanofibers
US12/666,168 US20100255581A1 (en) 2007-06-22 2008-06-20 Stimuli responsive nanofibers

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2008/067708 A-371-Of-International WO2009002858A2 (en) 2007-06-22 2008-06-20 Stimuli responsive nanofibers

Related Child Applications (1)

Application Number Title Priority Date Filing Date
US13/710,390 Division US9116144B2 (en) 2007-06-22 2012-12-10 Methods for preparing thermally responsive cell culture surfaces

Publications (1)

Publication Number Publication Date
US20100255581A1 true US20100255581A1 (en) 2010-10-07

Family

ID=40186249

Family Applications (3)

Application Number Title Priority Date Filing Date
US12/666,168 Abandoned US20100255581A1 (en) 2007-06-22 2008-06-20 Stimuli responsive nanofibers
US13/710,390 Active 2028-10-28 US9116144B2 (en) 2007-06-22 2012-12-10 Methods for preparing thermally responsive cell culture surfaces
US14/804,105 Abandoned US20160040121A1 (en) 2007-06-22 2015-07-20 Thermally responsive cell culture surfaces

Family Applications After (2)

Application Number Title Priority Date Filing Date
US13/710,390 Active 2028-10-28 US9116144B2 (en) 2007-06-22 2012-12-10 Methods for preparing thermally responsive cell culture surfaces
US14/804,105 Abandoned US20160040121A1 (en) 2007-06-22 2015-07-20 Thermally responsive cell culture surfaces

Country Status (6)

Country Link
US (3) US20100255581A1 (en)
EP (1) EP2171135A2 (en)
JP (1) JP5196684B2 (en)
AU (1) AU2008268566A1 (en)
CA (1) CA2691540A1 (en)
WO (1) WO2009002858A2 (en)

Cited By (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090285718A1 (en) * 2008-05-15 2009-11-19 Marc Privitera Polymer Active Complex Fibers
US20110173971A1 (en) * 2010-01-15 2011-07-21 Syracuse University Stimuli-responsive product
WO2012058464A2 (en) * 2010-10-28 2012-05-03 The Regents Of The University Of Michigan Multiphasic polymeric particles capable of shape-shifting via environmental stimulation
US20140264080A1 (en) * 2013-03-15 2014-09-18 Palo Alto Research Center Incorporated Phase-change enabled flow field visualization
US20140335610A1 (en) * 2011-11-20 2014-11-13 Tokyo Women's Medical University Cell culture substrate, and method for manufacturing same
WO2015054677A1 (en) * 2013-10-12 2015-04-16 Innovative Surface Technologies, Inc. Tissue scaffolds for electrically excitable cells
US9482861B2 (en) 2010-10-22 2016-11-01 The Regents Of The University Of Michigan Optical devices with switchable particles
US20180127700A1 (en) * 2015-05-21 2018-05-10 University Of South Florida Cell Culture Substrate for Rapid Release and Re-Plating
US10073024B2 (en) 2012-10-29 2018-09-11 The Regents Of The University Of Michigan Microfluidic device and method for detecting rare cells
US10130946B2 (en) 2011-09-30 2018-11-20 The Regents Of The University Of Michigan System for detecting rare cells
US10317406B2 (en) * 2015-04-06 2019-06-11 The Regents Of The University Of Michigan System for detecting rare cells
CN111065727A (en) * 2017-07-13 2020-04-24 阿莫生命科学有限公司 Cell culture container
JP2020157190A (en) * 2019-03-25 2020-10-01 株式会社日立ハイテクサイエンス Polymer fiber for separating biological component, column for separating biological component, measuring device and biological component separating device
US10935550B2 (en) 2011-09-30 2021-03-02 The Regents Of The University Of Michigan Functionalized graphene oxide system for detecting rare cells

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7772393B2 (en) 2005-06-13 2010-08-10 Innovative Surface Technologies, Inc. Photochemical crosslinkers for polymer coatings and substrate tie-layer
WO2009002869A2 (en) 2007-06-22 2008-12-31 Innovative Surface Technologies, Inc. Nanofibers containing latent reactive groups
US8691983B2 (en) * 2009-03-03 2014-04-08 Innovative Surface Technologies, Inc. Brush polymer coating by in situ polymerization from photoreactive surface
CN101538747B (en) * 2009-04-21 2011-08-31 东华大学 Shaping method of dry-like method electrostatic spinning of high polymer/ionic liquid spinning solution system
US8795561B2 (en) 2010-09-29 2014-08-05 Milliken & Company Process of forming a nanofiber non-woven containing particles
US8889572B2 (en) 2010-09-29 2014-11-18 Milliken & Company Gradient nanofiber non-woven
CN102733088B (en) * 2012-07-19 2014-05-07 哈尔滨工业大学 Thermo-sensitive poly N-isopropylacrylamide/polyurethane medicine-loading electro-spun fibrous membrane and preparation method thereof
JP6123247B2 (en) * 2012-11-15 2017-05-10 大日本印刷株式会社 Method for producing cell culture substrate having temperature responsiveness
EP2944711B1 (en) * 2013-01-11 2017-12-27 National Institute for Materials Science Nanofiber having self-heating properties and biologically active substance release properties, production method for same, and nonwoven fabric having self-heating properties and biologically active substance release capabilities
CN104414772A (en) * 2013-09-06 2015-03-18 山东百多安医疗器械有限公司 In-vivo degradable and absorbable artificial medical tissue repairing film
JP6229503B2 (en) * 2014-01-09 2017-11-15 大日本印刷株式会社 Temperature-responsive cell culture substrate and method for producing the same
JP6229502B2 (en) * 2014-01-09 2017-11-15 大日本印刷株式会社 Method for producing cell culture substrate having temperature responsiveness
ES2869283T3 (en) * 2015-11-02 2021-10-25 Fujifilm Corp Antitumor therapeutic agent containing gemcitabine liposome composition and kit
WO2017136334A1 (en) * 2016-02-01 2017-08-10 Theradep Technologies Inc. Systems and methods for delivering therapeutic agents
CN105797209B (en) * 2016-04-08 2019-03-01 深圳市第二人民医院 A kind of implantation titanium net of temperature self adjusting and preparation method thereof
JP6718610B2 (en) * 2016-05-09 2020-07-08 学校法人 関西大学 Cell culture substrate, method for producing the same, and method for controlling physical properties of cell culture substrate
CA3053898A1 (en) 2017-02-17 2018-08-23 The Research Foundation For The State University Of New York High-flux thin-film nanocomposite reverse osmosis membrane for desalination
CN109253740B (en) * 2018-09-10 2021-02-12 中原工学院 Capacitive sensor based on nanofiber core-spun yarn and preparation method thereof
CN112158922A (en) * 2020-09-08 2021-01-01 上海交通大学 Electrodialysis mixed salt recycling device
CN112430898B (en) * 2020-11-11 2022-06-07 山东大学 Thermal or solvent dual-stimulus color-change response nanofiber membrane and preparation method and application thereof

Citations (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3580927A (en) * 1967-11-24 1971-05-25 Minnesota Mining & Mfg Ultraviolet light inhibitors
US3959078A (en) * 1973-05-18 1976-05-25 Midwest Research Institute Enzyme immobilization with a thermochemical-photochemical bifunctional agent
US4043331A (en) * 1974-08-05 1977-08-23 Imperial Chemical Industries Limited Fibrillar product of electrostatically spun organic material
US4266055A (en) * 1980-05-07 1981-05-05 Nippon Kasei Chemical Co., Ltd. Tris(3-acetylthiopropyl)isocyanurate and preparation thereof
US4605413A (en) * 1983-09-19 1986-08-12 The University Of Alabama At Birmingham Stimulation of chemotaxis by chemotactic peptides
US4722906A (en) * 1982-09-29 1988-02-02 Bio-Metric Systems, Inc. Binding reagents and methods
US4973493A (en) * 1982-09-29 1990-11-27 Bio-Metric Systems, Inc. Method of improving the biocompatibility of solid surfaces
US5002582A (en) * 1982-09-29 1991-03-26 Bio-Metric Systems, Inc. Preparation of polymeric surfaces via covalently attaching polymers
US5202361A (en) * 1991-12-23 1993-04-13 Minnesota Mining And Manufacturing Company Pressure-sensitive adhesive
US5258041A (en) * 1982-09-29 1993-11-02 Bio-Metric Systems, Inc. Method of biomolecule attachment to hydrophobic surfaces
US5331027A (en) * 1987-09-02 1994-07-19 Sterilization Technical Services, Inc. Lubricious hydrophilic coating, resistant to wet abrasion
US5414075A (en) * 1992-11-06 1995-05-09 Bsi Corporation Restrained multifunctional reagent for surface modification
US5522879A (en) * 1991-11-12 1996-06-04 Ethicon, Inc. Piezoelectric biomedical device
US5563056A (en) * 1992-02-13 1996-10-08 Bsi Corporation Preparation of crosslinked matrices containing covalently immobilized chemical species and unbound releasable chemical species
US5714360A (en) * 1995-11-03 1998-02-03 Bsi Corporation Photoactivatable water soluble cross-linking agents containing an onium group
US5942555A (en) * 1996-03-21 1999-08-24 Surmodics, Inc. Photoactivatable chain transfer agents and semi-telechelic photoactivatable polymers prepared therefrom
US6096369A (en) * 1997-06-28 2000-08-01 Huels Aktiengesellschaft Process for hydrophilicizing the surface of polymeric substrates with a macroinitiator as primer
US6278018B1 (en) * 1999-12-14 2001-08-21 Surmodics, Inc. Surface coating agents
US20020004140A1 (en) * 1999-09-22 2002-01-10 Swan Dale G. Water-soluble coating agents bearing initiator groups
US6391948B1 (en) * 1999-12-14 2002-05-21 3M Innovative Properties Company Triazine compounds and use thereof
US6395429B1 (en) * 1999-06-28 2002-05-28 Samsung Sdi Co., Ltd. Solid polymer electrolyte employing a crosslinking agent
US20030165613A1 (en) * 2001-12-21 2003-09-04 Chappa Ralph A. Reagent and method for providing coatings on surfaces
US20060030669A1 (en) * 2004-08-06 2006-02-09 Surmodics, Inc. Thermally-reactive polymers
US20070082393A1 (en) * 2005-07-20 2007-04-12 Muhammad Lodhi Polymer coated nanofibrillar structures and methods for cell maintenance and differentiation
US20080021126A1 (en) * 2004-02-02 2008-01-24 Kurt Dietliker Functionalized Photoinitiators
US20110020917A1 (en) * 2007-06-22 2011-01-27 Innovative Surface Technologies, Inc. Nanofibers containing latent reactive groups

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5742742A (en) 1980-08-26 1982-03-10 Sumitomo Chem Co Ltd Light stabilizer
JPS57117564A (en) 1981-01-12 1982-07-22 Sumitomo Chem Co Ltd Stabilized synthetic resin composition
JPS5943061A (en) 1982-09-06 1984-03-09 Adeka Argus Chem Co Ltd Stabilized synthetic resin composition
US5284766A (en) 1989-02-10 1994-02-08 Kao Corporation Bed material for cell culture
JPH0541976A (en) * 1991-08-09 1993-02-23 W R Grace & Co Test base material for cell cultivation and its preparation
BR9207079A (en) 1992-02-10 1995-12-05 Minnesota Mining & Mfg Radiation crosslinkable composition
US6369123B1 (en) 1995-08-14 2002-04-09 3M Innovative Properties Company Radiation-crosslinkable elastomers and photocrosslinkers therefor
CA2258523A1 (en) 1996-07-18 1998-01-29 Ciba Specialty Chemicals Holding Inc. Polyoxyalkene substituted and bridged triazine, benzotriazole and benzophenone derivatives as uv absorbers
US5997961A (en) 1998-03-06 1999-12-07 Battelle Memorial Institute Method of bonding functional surface materials to substrates and applications in microtechnology and antifouling
US6709742B2 (en) 1998-05-18 2004-03-23 Dow Global Technologies Inc. Crosslinked elastic fibers
US6737447B1 (en) * 1999-10-08 2004-05-18 The University Of Akron Nitric oxide-modified linear poly(ethylenimine) fibers and uses thereof
WO2001040367A1 (en) 1999-11-29 2001-06-07 Ciba Specialty Chemicals Holding Inc. Dimeric light stabilizers for polyolefins and polyolefin copolymers
US7405078B2 (en) 2000-03-16 2008-07-29 Cellseed Inc. Bed material for cell culture, method for co-culture of cell and co-cultured cell sheet obtainable therefrom
US6706408B2 (en) 2002-05-16 2004-03-16 Surmodics, Inc. Silane coating composition
WO2004044281A2 (en) * 2002-11-12 2004-05-27 The Regents Of The University Of California Nano-porous fibers and protein membranes
US7704740B2 (en) * 2003-11-05 2010-04-27 Michigan State University Nanofibrillar structure and applications including cell and tissue culture
EP1748064B1 (en) 2004-04-25 2019-04-17 CellSeed Inc. Cultured periodontal ligament cell sheet, process for producing the same and method of use thereof
DK1857126T3 (en) 2005-02-28 2019-02-04 Cellseed Inc CULTIVATED CELL LAYER, MANUFACTURING THEREOF AND USING THEREOF.
US7772393B2 (en) 2005-06-13 2010-08-10 Innovative Surface Technologies, Inc. Photochemical crosslinkers for polymer coatings and substrate tie-layer
US7989619B2 (en) 2005-07-14 2011-08-02 Innovative Surface Technoloiges, Inc. Nanotextured surfaces
KR101325856B1 (en) * 2005-09-30 2013-11-05 닛산 가가쿠 고교 가부시키 가이샤 Chip provided with film having hole pattern with the use of thermoresponsive polymer and method of producing the same
US20070092493A1 (en) 2005-10-24 2007-04-26 Hsing-Wen Sung Living cell sheet
US20070116678A1 (en) 2005-11-23 2007-05-24 Hsing-Wen Sung Medical device with living cell sheet
EP1873205A1 (en) 2006-06-12 2008-01-02 Corning Incorporated Thermo-responsive blends and uses thereof
US20080050423A1 (en) 2006-08-23 2008-02-28 National Tsing Hua University Biopolymer-bioengineered cell sheet construct

Patent Citations (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3580927A (en) * 1967-11-24 1971-05-25 Minnesota Mining & Mfg Ultraviolet light inhibitors
US3959078A (en) * 1973-05-18 1976-05-25 Midwest Research Institute Enzyme immobilization with a thermochemical-photochemical bifunctional agent
US4043331A (en) * 1974-08-05 1977-08-23 Imperial Chemical Industries Limited Fibrillar product of electrostatically spun organic material
US4266055A (en) * 1980-05-07 1981-05-05 Nippon Kasei Chemical Co., Ltd. Tris(3-acetylthiopropyl)isocyanurate and preparation thereof
US4973493A (en) * 1982-09-29 1990-11-27 Bio-Metric Systems, Inc. Method of improving the biocompatibility of solid surfaces
US4722906A (en) * 1982-09-29 1988-02-02 Bio-Metric Systems, Inc. Binding reagents and methods
US5002582A (en) * 1982-09-29 1991-03-26 Bio-Metric Systems, Inc. Preparation of polymeric surfaces via covalently attaching polymers
US5258041A (en) * 1982-09-29 1993-11-02 Bio-Metric Systems, Inc. Method of biomolecule attachment to hydrophobic surfaces
US4605413A (en) * 1983-09-19 1986-08-12 The University Of Alabama At Birmingham Stimulation of chemotaxis by chemotactic peptides
US5331027A (en) * 1987-09-02 1994-07-19 Sterilization Technical Services, Inc. Lubricious hydrophilic coating, resistant to wet abrasion
US5522879A (en) * 1991-11-12 1996-06-04 Ethicon, Inc. Piezoelectric biomedical device
US5202361A (en) * 1991-12-23 1993-04-13 Minnesota Mining And Manufacturing Company Pressure-sensitive adhesive
US5563056A (en) * 1992-02-13 1996-10-08 Bsi Corporation Preparation of crosslinked matrices containing covalently immobilized chemical species and unbound releasable chemical species
US5637460A (en) * 1992-11-06 1997-06-10 Bsi Corporation Restrained multifunctional reagent for surface modification
US5414075A (en) * 1992-11-06 1995-05-09 Bsi Corporation Restrained multifunctional reagent for surface modification
US5714360A (en) * 1995-11-03 1998-02-03 Bsi Corporation Photoactivatable water soluble cross-linking agents containing an onium group
US6077698A (en) * 1995-11-03 2000-06-20 Surmodics, Inc. Photoactivatable cross-linking agents containing charged groups for water solubility
US5942555A (en) * 1996-03-21 1999-08-24 Surmodics, Inc. Photoactivatable chain transfer agents and semi-telechelic photoactivatable polymers prepared therefrom
US6096369A (en) * 1997-06-28 2000-08-01 Huels Aktiengesellschaft Process for hydrophilicizing the surface of polymeric substrates with a macroinitiator as primer
US6395429B1 (en) * 1999-06-28 2002-05-28 Samsung Sdi Co., Ltd. Solid polymer electrolyte employing a crosslinking agent
US20020004140A1 (en) * 1999-09-22 2002-01-10 Swan Dale G. Water-soluble coating agents bearing initiator groups
US6391948B1 (en) * 1999-12-14 2002-05-21 3M Innovative Properties Company Triazine compounds and use thereof
US6278018B1 (en) * 1999-12-14 2001-08-21 Surmodics, Inc. Surface coating agents
US20030165613A1 (en) * 2001-12-21 2003-09-04 Chappa Ralph A. Reagent and method for providing coatings on surfaces
US7348055B2 (en) * 2001-12-21 2008-03-25 Surmodics, Inc. Reagent and method for providing coatings on surfaces
US20080021126A1 (en) * 2004-02-02 2008-01-24 Kurt Dietliker Functionalized Photoinitiators
US20060030669A1 (en) * 2004-08-06 2006-02-09 Surmodics, Inc. Thermally-reactive polymers
US20070082393A1 (en) * 2005-07-20 2007-04-12 Muhammad Lodhi Polymer coated nanofibrillar structures and methods for cell maintenance and differentiation
US20110020917A1 (en) * 2007-06-22 2011-01-27 Innovative Surface Technologies, Inc. Nanofibers containing latent reactive groups

Cited By (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8349449B2 (en) * 2008-05-15 2013-01-08 The Clorox Company Polymer active complex fibers
US20090285718A1 (en) * 2008-05-15 2009-11-19 Marc Privitera Polymer Active Complex Fibers
US20110173971A1 (en) * 2010-01-15 2011-07-21 Syracuse University Stimuli-responsive product
US8683798B2 (en) 2010-01-15 2014-04-01 Syracuse University Stimuli-responsive product
US9482861B2 (en) 2010-10-22 2016-11-01 The Regents Of The University Of Michigan Optical devices with switchable particles
WO2012058464A3 (en) * 2010-10-28 2012-07-12 The Regents Of The University Of Michigan Multiphasic polymeric particles capable of shape-shifting via environmental stimulation
WO2012058464A2 (en) * 2010-10-28 2012-05-03 The Regents Of The University Of Michigan Multiphasic polymeric particles capable of shape-shifting via environmental stimulation
US10935550B2 (en) 2011-09-30 2021-03-02 The Regents Of The University Of Michigan Functionalized graphene oxide system for detecting rare cells
US10130946B2 (en) 2011-09-30 2018-11-20 The Regents Of The University Of Michigan System for detecting rare cells
US20140335610A1 (en) * 2011-11-20 2014-11-13 Tokyo Women's Medical University Cell culture substrate, and method for manufacturing same
US10073024B2 (en) 2012-10-29 2018-09-11 The Regents Of The University Of Michigan Microfluidic device and method for detecting rare cells
US10677708B2 (en) 2012-10-29 2020-06-09 The Regents Of The University Of Michigan Microfluidic device and method for detecting rare cells
US9182420B2 (en) * 2013-03-15 2015-11-10 Palo Alto Research Center Incorporated Phase-change enabled flow field visualization
US20140264080A1 (en) * 2013-03-15 2014-09-18 Palo Alto Research Center Incorporated Phase-change enabled flow field visualization
WO2015054677A1 (en) * 2013-10-12 2015-04-16 Innovative Surface Technologies, Inc. Tissue scaffolds for electrically excitable cells
US11407977B2 (en) 2013-10-12 2022-08-09 Innovative Surface Technologies, Inc. Tissue scaffolds for electrically excitable cells
US10317406B2 (en) * 2015-04-06 2019-06-11 The Regents Of The University Of Michigan System for detecting rare cells
US20180127700A1 (en) * 2015-05-21 2018-05-10 University Of South Florida Cell Culture Substrate for Rapid Release and Re-Plating
CN111065727A (en) * 2017-07-13 2020-04-24 阿莫生命科学有限公司 Cell culture container
EP3653696A4 (en) * 2017-07-13 2021-05-26 Amolifescience Co., Ltd. Cell culture vessel
US11248201B2 (en) 2017-07-13 2022-02-15 Amolifescience Co., Ltd. Cell culture vessel
JP2020157190A (en) * 2019-03-25 2020-10-01 株式会社日立ハイテクサイエンス Polymer fiber for separating biological component, column for separating biological component, measuring device and biological component separating device

Also Published As

Publication number Publication date
JP5196684B2 (en) 2013-05-15
WO2009002858A3 (en) 2009-08-27
US20160040121A1 (en) 2016-02-11
WO2009002858A2 (en) 2008-12-31
US20130171331A1 (en) 2013-07-04
JP2010530931A (en) 2010-09-16
US9116144B2 (en) 2015-08-25
EP2171135A2 (en) 2010-04-07
CA2691540A1 (en) 2008-12-31
AU2008268566A1 (en) 2008-12-31

Similar Documents

Publication Publication Date Title
US9116144B2 (en) Methods for preparing thermally responsive cell culture surfaces
US8709809B2 (en) Nanofibers containing latent reactive groups
Ren et al. Electrospun PCL/gelatin composite nanofiber structures for effective guided bone regeneration membranes
Tan et al. Electrospun cellulose acetate butyrate/polyethylene glycol (CAB/PEG) composite nanofibers: A potential scaffold for tissue engineering
Cipitria et al. Design, fabrication and characterization of PCL electrospun scaffolds—a review
Ku et al. Human endothelial cell growth on mussel-inspired nanofiber scaffold for vascular tissue engineering
Rim et al. Mussel-inspired surface modification of poly (L-lactide) electrospun fibers for modulation of osteogenic differentiation of human mesenchymal stem cells
Bhattarai et al. Hydrophilic nanofibrous structure of polylactide; fabrication and cell affinity
Gümüşderelioğlu et al. A novel dermal substitute based on biofunctionalized electrospun PCL nanofibrous matrix
Jiang et al. Polycaprolactone nanofibers containing vascular endothelial growth factor-encapsulated gelatin particles enhance mesenchymal stem cell differentiation and angiogenesis of endothelial cells
Bockelmann et al. Functionalization of electrospun poly (ε-caprolactone) fibers with the extracellular matrix-derived peptide GRGDS improves guidance of Schwann cell migration and axonal growth
Vatankhah et al. Phenotypic modulation of smooth muscle cells by chemical and mechanical cues of electrospun tecophilic/gelatin nanofibers
WO2010057142A2 (en) Surface modification of silk fibroin matrices with poly(ethylene glycol) useful as anti adhesion barriers and anti thrombotic materials
Evrova et al. Hybrid randomly electrospun poly (lactic-co-glycolic acid): poly (ethylene oxide)(PLGA: PEO) fibrous scaffolds enhancing myoblast differentiation and alignment
CA2482086A1 (en) Polymeric fibre and method for making same
Wang et al. Facile strategy to generate aligned polymer nanofibers: effects on cell adhesion
Amokrane et al. Electrospun poly (ε-caprolactone) fiber scaffolds functionalized by the covalent grafting of a bioactive polymer: surface characterization and influence on in vitro biological response
Joseph et al. Insights into the biomechanical properties of plasma treated 3D printed PCL scaffolds decorated with gold nanoparticles
Mi et al. Properties and fibroblast cellular response of soft and hard thermoplastic polyurethane electrospun nanofibrous scaffolds
Sardella et al. Improving internal cell colonization of porous scaffolds with chemical gradients produced by plasma assisted approaches
Martelli et al. Combining biologically active β-lactams integrin agonists with poly (l-lactic acid) nanofibers: enhancement of human mesenchymal stem cell adhesion
Yang et al. Coaxial bioelectrospinning of P34HB/PVA microfibers biomimetic scaffolds with simultaneity cell-laden for improving bone regeneration
Montazeri¹ et al. Compatibility of cardiac muscle cells on coated-gelatin electro-spun polyhydroxybutyrate/valerate nano fibrous film
Li et al. Biofunctionalized nanofibrous bilayer scaffolds for enhancing cell adhesion, proliferation and osteogenesis
Jang et al. Fibroblast culture on poly (L-lactide-co-ɛ-caprolactone) an electrospun nanofiber sheet

Legal Events

Date Code Title Description
AS Assignment

Owner name: INNOVATIVE SURFACE TECHNOLOGIES, INC., MINNESOTA

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:NAQVI, TAHMINA;WEN, JIE;GUIRE, PATRICK;REEL/FRAME:026221/0029

Effective date: 20100524

STCB Information on status: application discontinuation

Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION